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Abstract
EXAMINATION OF CRANIAL ELECTROTHERAPY STIMULATION (CES)
ON DEPRESSIVE AND ANXIETY SYMPTOMS OF CAREGIVERS:
A DOUBLE-BLIND EXPERIMENTAL STUDY
Reginald Gerard Jefferson
St. Mary’s University, 2020
Dissertation Adviser: Melanie Harper, Ph.D.

The caregiver population has recently been recognized in society as a population
highly susceptible to problems related to increased anxiety, burden, and abnormal
psychological well-being. This experimental pretest post-test 2-group double-blind study
was designed to measure the efficacy of cranial electrotherapy stimulation (CES) on
anxiety and depressive symptoms of caregivers. Changes in anxiety and depressive
symptoms were identified using pre- and posttest measures of State-Trait Anxiety
Inventory and Beck Depression Inventory. Caregivers were assigned a pre-coded CES
device. Neither the researcher nor the caregiver knew whether a device was active or
sham until the completion of the entire study. This experimental design used a repeated
measure t-test for quantitative statistics. Following an analysis of the data, the
researcher’s hypotheses that CES would help reduce symptoms of anxiety and depression
more significantly than a placebo were not supported. Both the treatment and control
groups experienced decreased anxiety and depressive symptoms, but the treatment
group’s decrease was not significantly greater than the control group’s decrease.
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Chapter 1
Introduction
Improvements in public health, medical advances, and the graying of the “baby
boomer” generation have contributed to the aging of the U.S. population (Chyung,
LePiane, Shamsy, & Radloff, 2018). Those aged 65 and older are expected to increase in
population from 10.9 % to 15.7% from 2010 to 2050 (Colby & Ortman, 2017), an
increase of 35 million people. Life expectancy of those aged 90 and older comprise 4.7 %
of this older population, and this population is expected to quadruple over the next four
decades (Colby & Ortman, 2017). In addition, more seniors are opting to remain in their
homes longer rather than to live in skilled nursing facilities (Chyung et al., 2018). With
these current trends, the need for caregivers will increase. However, current research has
shown that caregivers have higher risks of adverse health and psychological effects
because of their caregiving role (National Alliance for Caregiving [NAC], 2015).
Additionally, few studies have investigated the effects of stress reduction interventions
for caregivers. It was this researcher’s purpose to investigate cranial electrotherapy
stimulation (CES) as a stress-reducing intervention for caregivers.
Throughout the progression of providing care, caregiving transitions may lead to
triggers for increased anxiety for caregivers (NAC, 2015). As caregivers assume their
caregiving role, they sometimes must relinquish or modify prior responsibilities. Changes
in family responsibility for caregivers can be stressful which could lead to dynamics in
the family changing significantly (Lorig, Ritter, Laurent, & Yank, 2017; Schulz, & Czaja,
2018). Additionally, the transition to a nursing home, or employing home care, may be
difficult. Caregiver compassion can lead to distress and increased anxiety if the caregiver
feels they are unable to adequately provide care and relieve suffering of their loved one

8

(Brooks, Fielding, Beattie, Edwards, & Hines, 2018). This distress is especially true for
end-stage caregiving as it carries the greatest burden for caregivers. High levels of stress
are typically associated with decisions for palliative care, life-sustaining technology, or to
withdraw care. All these issues lead to a problem with stress for caregivers. They need
anxiety-reducing interventions to help them deal with stressors within their caregiving
role.
Statement of the Problem
In numerous studies, multiple researchers have reported that caregivers have
higher risk of adverse health, psychological, and financial effects because of increased
anxiety in their caregiver role (Ashley, O’Connor, & Jones, 2011; Harris, Durkin, Allen,
DeCoster, & Burgio, 2011; King, Ainsworth, Ronen, & Hartke, 2010; MacNeil et al.,
2010; Martin et al., 2011; Pioli, 2010; Schulz, & Czaja, 2018; Turner et al., 2010).
Researchers have conducted studies that introduce interventions to reduce anxiety and
depressive symptoms for caregivers (Epstein-Lubow, McBee, Darling, Armey, & Miller,
2011; Lopez, Crespo, & Zarit, 2007; Lorig et al., 2017; O'Connell, Heslop, & Fennessey,
2010; Williams et al., 2010;). To reduce anxiety and depressive symptoms in caregivers,
researchers in previous studies focused on two types of interventions: reduce caregiving
time or provide information and develop coping skills (NAC, 2015).
To date, no other research study offers a potential intervention to reduce anxiety and
depressive symptoms in the caregiver population outside of the aforementioned two types
of interventions. Given the body of research over the past decade for interventions,
limitations exist in prior studies. Reducing levels of stress for caregivers does not
necessarily reduce anxiety and depression in caregivers (Brooks et al., 2018; Gottlieb &
Johnson, 2010). Caregivers who provide intermittent care based on the progression of
9

care commitment may still experience anxiety and depressive symptoms regarding their
caregiving responsibility. In addition, interventions regarding increased knowledge and
providing coping skills also fall short in reducing stress and depression (Brodaty, Green,
& Koschera, 2003). These types of interventions have traditionally relied on professional
seminars and forums to disseminate information. This requires time away from
caregiving and competes with caregivers’ already packed schedules. Due to low
participation rates and high attrition, these types of interventions have historically not
been very successful. Given the limitations of previous research for these types of
interventions, it is imperative to examine alternative methods of anxiety and depressive
symptom reduction for caregivers.
Purpose of the Study
This researcher sought to explore the effectiveness of cranial electrotherapy
stimulation (CES) as an alternative treatment for caregivers to anxiety and depressive
symptoms. A reduction in anxiety and depressive symptoms can lead to a reduction in
caregiver burnout, the promotion of better family relations, and the experience of less
stress and depression (Brodaty et al., 2003; Dickinson et al., 2017; Schulz, & Czaja,
2018). Success in assisting care recipients’ sense of self-worth and increased motivation
are also benefits in reducing stress and depression for caregivers.
Research Questions and Hypotheses
This study examined the following research questions:
RQ1: Did caregivers receiving active CES treatments experience a greater
reduction of anxiety symptoms than caregivers receiving the CES sham
treatment?
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Ho1: Participants who received active CES treatments experienced a reduction of
anxiety as evidenced by the reduction of STAI scores against subjects in the
CES sham group.
RQ2: Did participants receiving active CES treatments experience a greater
reduction of depressive symptoms as evidenced by the reduction of the Beck
Depression Inventory (BDI) scores against subjects in the CES sham group?
Ho2: Participants who received active CES treatments experienced a reduction of
depression as evidenced by the reduction of the BDI scores against subjects
in the CES sham group.
RQ3: Is there a relationship between anxiety symptoms and depressive symptoms
in caregivers?
Ho3: There is a relationship between STAI scores and BDI scores.
Rationale and Justification of the Study
Caregiving roles can be stressful and burdensome (Harris et al., 2011; Roth,
Fredman, & Haley, 2015) and have all the features of chronic stress experiences. Over
long periods of time, a caregiver role creates physical and psychological strain. Such a
role also has high levels of uncontrollability, lacks predictability, and could create
multiple stressors in work and family relationships. Caregiving requires high levels of
mindfulness (Harris et al., 2011; Roth et al., 2015).
Medical advances including home care technology, shorter hospital stays, and
limited discharge planning, have placed increased demands on caregivers (NAC, 2015).
However, their duties and responsibilities may be stressors in their lives that may increase
anxiety and depression. Duties include assisting with activities of daily living (ADL)
including toiletry issues, bathing, dressing, and may provide help with mobility such as
11

getting out of bed and walking. Some undertake medical duties like administering
medication or changing dressings (NAC, 2015). Duties may also include assisting with
instrumental activities of daily living (IADL) like supervising and monitoring the carerecipients, as well as taking them to their appointments. Other IADLs include shopping,
cooking, and cleaning, along with assisting with financial matters and other paperwork.
Caregivers often provide these responsibilities around the clock while juggling other
personal responsibilities. This may cause high levels of anxiety in caregivers that could
lead to increased anxiety, depression, and other physical or psychological ailments.
Anxiety is a reaction to long-term stress that has both psychological and physical
features (McLeod, 2010). The brain works differently when it becomes anxious. Brain
structures typically stay the same, but how the brain processes that information is
different. Brain functioning occurs across many different parts, but with anxiety, the main
part is the limbic striatal loop (McLeod, 2010). When this loop is in overdrive, feelings
and emotions may seem overly important. Each part of this system plays an important
role in anxiety, and it starts with the stress response (McLeod, 2010).
Stress is a bio-psychological response that we experience when encountering a
threat that we perceive we do not have adequate resources to handle (McLeod, 2010).
Stressor are the stimulus causing the stress, e.g., caregiving role and responsibility. First,
the body decides if a situation is stressful. If so, the hypothalamus, the part of the brain
responsible for stress response, activates and sends a signal to the adrenal medulla and
the pituitary gland (McLeod, 2010). Once triggered, signals are sent to the pituitary gland
and adrenal medulla. The fight-or-flight response sends a signal through the
sympathomedullary pathway (SAM). However, the hypothalamic pituitary-adrenal
system (HPA) processes long-term stress (McLeod, 2010).
12

When a stressor activates the HPA, the pituitary gland is stimulated by the
hypothalamus and secretes adrenocorticotropic hormones (ACTH). These hormones
produce cortisol, which enables the body to sustain the steady supply of blood sugar
needed to cope with continued stressors (McLeod, 2010). During this process, the
immune system is suppressed. Sustained levels of cortisol due to chronic stress can lead
to unhealthy bone and muscle structure. High, sustained levels of cortisol may (a) slow
normal cell regeneration and healing, (b) reduce the biochemical necessary to making
vital hormones, (c) impair digestion and metabolism, (d) diminish mental functioning, (e)
interfere with endocrine functions, and (f) weaken the immune system (McLeod, 2010).
Caregiver anxiety is the state of long-term chronic stress due to caregiving roles
and responsibilities (McLeod, 2010). Some caregivers face years or decades of
caregiving responsibility. Increased stress may persist if there is no hope that the carerecipient is getting better. Without support and adequate interventions, the stress of
caregiving may leave caregivers to a wide range of physical, psychological, and
emotional problems, ranging from heart disease and depression to death (Jain, 2014).
Caregivers who provide care for dementia care recipients are 63% more likely to have an
increased risk of death because related to their caregiving role than any other type of
caregiver (Tremont, 2011).
Limitations
Research methodologies have limitations (Krathwohl, 2009). Researchers should
be able to recognize and determine if the benefits outweigh the cost of the study
(Krathwohl, 2009). The researcher identified the following limitations that may reduce
efficacy of treatment and of identified solutions. A limitation is the possibility there will
not be a true randomization process to the identified population. This study will recruit
13

participants from the Houston area. Due to caregiving work schedules, there may be a
lack of available caregivers willing to participate. Additionally, there may be constraints
because CES may seem uncomfortable to some caregivers or they may not have interest
in the study. Another limitation is that some participants may not complete the full 21day protocol for using the CES device.
Definitions of Terms
The following definitions enhance the understanding of this study.
Anxiety symptoms. The uneasy feelings with apprehension from a real or
perceived threat of imminent danger (McLeod, 2010). In this study, caregiver anxiety
symptoms were measured using STAI scores.
Caregiver. The two types of caregivers are formal and informal. Formal
caregivers are paid or volunteer and provide care through service systems that include
non-profit or for-profit home care agencies, assisted living facilities, intermediate care
facilities, nursing homes, community services, hospice organizations, churches, or charity
service groups (NAC, 2015). Informal caregivers include family members, friends, and
neighbors who provide unpaid caregiving services out of friendship, love, respect, or
obligation, to disabled or chronically ill individuals (NAC, 2015). In this study, the term,
“caregiver” were used to reflect both informal and formal caregivers over the age of 18.
Cranial electrotherapy stimulation (CES). Introduced to the United States of
America over 50 years ago, CES is “any small electrical current that is passed across the
head for therapeutic purposes” (Kirsch, 2002, p. 3). Other names found in the literature
for CES are electrosleep, transcranial electrical stimulation, or cerebral
electrostimulation (Kirsch, 2002). In this study, CES devices, known as Alpha-Stim,
were used to administer the CES treatment.
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Depressive symptoms. Feelings of intense sadness, including helplessness, and
feeling hopeless or worthless (Beck, Steer, & Garbin, 1988). These feelings may last
from many days or weeks to several months (Beck et al., 1988). They may also keep one
from functioning normally. In this study, caregiver depressive symptoms were measured
using Beck’s Depression Inventory scores.
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Chapter 2
Literature Review
Caregivers are a critical resource to national healthcare. However, the current
body of research and clinical observation has shown that assuming a caregiving role can
increase anxiety that may cause adverse health effects (Ashley et al., 2011; Harris et al.,
2011; King et al., 2010; Lockenhoff, Duberstein, Friedman, & Costa, 2011; MacNeil et
al., 2010; Martin et al., 2011; Pioli, 2010; Turner et al., 2010; Wooden, 2013). Physical
and psychological strain occurs over time, with caregiving, accompanied by high levels
of unpredictability and uncontrollability. Such strain can create secondary stress across
work and family relationships (Schulz & Sherwood, 2008).
Formal Versus Informal Caregivers
There are two types of caregivers: informal and formal. Known as home care
workers, home health aides, or personal care aides, formal caregivers are increasingly in
demand as the older population increases (U.S. Bureau of Labor Statistics [BLS], 2016).
Families of loved ones needing care are hiring formal caregivers to provide in-home care.
Formal caregivers help those who are disabled, chronically ill, or cognitively impaired
and need assistance (BLS, 2016). The employment rate of formal caregivers is expected
to increase to 69% by 2020. The BLS (2016) reported that formal caregiver positions are
growing faster than most occupations. However, this high demand does not translate into
high wages for formal caregivers. In practice, formal caregiver occupations are among
the lowest paid occupations in the nation (BLS, 2016). In some states, wages fall below
the federal poverty line. Of the 2.5 million formal caregivers in the U.S., most are
disproportionately female immigrants or women of color and on public assistance like
food stamps or Medicaid (Colby & Ortman, 2017).
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In contrast, informal care giving is unpaid and provided by a family member,
friend, or neighbor out of love, respect, or obligation (Chyung et al., 2018)). This type of
caregiver outnumbers formal caregivers. Estimates for total number of informal
caregivers range from 20 to 50 million people. This number represents 20% of the
population providing full or part-time care (NAC, 2015). Colby and Ortman, (2017)
reported that the typical informal caregiver is a female in her mid-40s with a full-time
job. This type of caregiver provides care for an average of 18 hours a week.
Among informal caregivers aged 20 to 75, 38% care for parents while 11% care
for their spouse (BLS, 2016). Two-thirds of caregivers who care for people 50 years old
or older and who work part-time or full-time reported rearranging their work schedule,
decreasing hours, or taking unpaid leaves to meet caregiving responsibilities (NAC,
2015). A recent study estimated that informal caregivers have lost about $660,000 in
wages over their lifetime due to work sacrifices (Chyung et al., 2018). The loss of
productivity to businesses due to caregivers taking time off is between 11 and 29 billion
dollars yearly. Informal caregivers’ mean time to provide care is approximately 4.5 years;
however, at least 20% are providing care five years or longer (NAC, 2015).
A progression of care commitment exists between informal and formal caregivers.
That progression is through intermittent, part-time, and full-time care. As caregiving
needs increase in intensity along with the number of hours required for care, the need for
formal caregiving increases. This in part is due to their training – or lack of training – to
address certain situations within their caregiving role. However, some informal
caregivers are unwilling to stop providing care for their loved one or family member even
when caregiving needs increase, and fail, or are unwilling, to realize they have reached
the time for formal caregiving to begin. (NAC, 2015). Unfortunately, informal caregivers
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may recognize the need for formal care, but the money does not exist to pay for it (NAC,
2015). This type of overload can cause increased anxiety, depression, or physical
ailments regardless of the level of commitment necessary when providing intermittent,
part-time, or full-time care.
Informal caregivers providing intermittent care give occasional attention to
patients who are still living in their home. These caregivers would typically live or work
close by and would stop by for occasional visits. Although the care is intermittent, a level
of daily stressors still exists because of the caregiving role.
Caregivers may provide part-time care if no extensive medical condition exists. In
this type of care, the care-recipient and informal caregiver usually live together. The
caregiver maintains a consistent work schedule while providing care. However, levels of
anxiety and stressors can still affect the caregiver. Caregivers who provide full-time care
often live with the care-recipient. Both informal and formal caregivers can provide this
type of care. Due to the demands of this type of care, caregivers often suffer depression,
social isolation, and other possible physical ailments (NAC, 2015). Usually during this
point in the progression of commitment, the caregiver must decide whether to go
completely with formal care or continue with informal care. These transitioning times are
also stressors for caregivers (NAC, 2015). To fully understand the effects of the
caregiving role on caregivers, one must have a basic understanding of the history of stress
and anxiety research.
Pioneers of Stress and Anxiety Research
During the early twentieth century, Walter Cannon, a Harvard Medical School
psychologist, and physiologist, first described the body’s reaction to stress (Cannon,
1932). While studying the physical reaction of lab animals when they are under stress, he
18

noticed changes in their stomach function when the animals were frightened or scared
(Cannon, 1932). Cannon continued to study physiological reactions to stress in the body
and identified the stress reaction as the fight or flight response. This reaction is also
known as acute stress response (Cannon, 1932). Cannon defined fight or flight response
as the body preparing itself when facing a threat; it either stands ground and fights or runs
away (Cannon, 1932).
The endocrinologist Selye (1975) first defined stress as the body’s nonspecific
response to demands made upon it. While observing changes in the body of lab rats
exposed to stressors, stress reactivity was summarized as general adaptation syndrome, a
three-phase process. Selye called the first phase the alarm reaction, explaining that in this
phase the body begins to show changes that are characteristic of exposure to a stressor.
Simultaneously, the body’s resistance to handle the stressor diminishes. Stressors that are
significantly strong, like extreme temperature, can ultimately cause death. Selye called
the second phase the state of resistance. In this phase, the body adapts to the exposure of
the stressor and resistance maintains. The bodily changes characteristic of exposure to the
stressor have disappeared and levels of resistance rise above normal (Selye, 1975).
Selye (1975) described the third stage of stress reactivity exhaustion. In this
phase, the body is no longer able to adjust or adapt to the long-term exposure of the
stressor. As a result, signs of the alarm reaction reappear, but this time the signs are
irreversible. Selye explained that stress can result from a good experience, like a
promotion, or from a bad experience, like a loss of a loved one. Both are experienced
physiologically, and we must learn how to adapt (Selye, 1975). Cannon (1932) and Selye
(1975) are not the only researches to study this topic.
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Other researchers have added to Selye and Cannon’s body of research to
illuminate how the body handles stress. One such scientist was Simeons (1961), who was
responsible for the link between stress and psychosomatic illness. Simeons (1961)
theorized that stress is due to a lack of inner peace. The neurologist Harold Wolf (1953)
contributed his understanding of the connection between the nervous system and diseases
like ulcers, colitis, and hypertension. He was first to establish a separate category of
illness he defined as psychosomatic. Cardiologists Friedman and Rosenman (1958)
developed their theory while observing patients with heart conditions while in the waiting
room of their office. Some of their patients were unable to sit for long periods of time but
rather sat on the edge of their seats and leapt up frequently.
Friedman and Rosenman (1958) went on to label this behavior as Type A
personality. People with Type A personality had a higher risk of heart disease and high
blood pressure than other personality types (Friedman & Rosenman, 1958). Simonton,
Matthews-Simonton, and Sparks (1980) developed a model for the emotional support of
cancer patients. They introduced the concept that a positive state of mind could influence
one’s ability to survive cancer. Cardiologists Benson and Klipper (1975) pioneered mindbody medicine when they introduced spirituality and healing into medicine. Psychiatrists
Holmes and Rahe (1967) examined the medical records of patients to determine if
stressful events caused illnesses and found 43 life events that were based on a relative
score. A positive correlation was found between their patients’ life events and illnesses.
Those results were published as the Holmes and Rahe Stress Scale (1967).
The link between stress and illness may explain why caregivers’ experience
adverse health effects in their caregiving role, as caregivers certainly experience stress in
carrying out their duties. Definitions differentiating stress and anxiety can be unclear at
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times. This lack of clarity is even found in the 2013 edition of the APA’s DSM-V. One
such reason is that the DSM-V has approximately 13 different diagnoses categorized
under anxiety disorder. In addition, there is overlap of symptoms between each diagnosis.
Another reason is that the two words are often interchangeable in the DSM-V. McLeod
(2010) found that symptoms of stress include headache, chest pain, increased blood
pressure, muscle aches, and shortness of breath, to name a few. The DSM-V lists
symptoms of stress for a panic attack as “palpitations, heart pounding, sweating,
trembling, shortness of breath, choking feeling, chest pain” (p. 432). Although the
symptoms are similar, they require different diagnoses. Stress is typically short-term and
resolved when the causing stressor is removed. In contrast, anxiety symptoms are usually
long-term and remain after the causing stressor is removed. Stress is the body’s physical
response to events and circumstances, whereas anxiety is the uneasy feeling regarding
apprehension from threat or imminent danger (Mayer, 2011). Mayer’s definition would
further imply that stress can lead to anxiety.
Caregiving touches almost every family in different ways. It is, therefore,
important to have interventions that reduce anxiety and depression in caregivers. To find
possible interventions, it would be helpful also to understand the physiological aspects.
To further understand how the body processes anxiety, one must first understand
neurotransmitters – the brain elements that comprise the brain messaging system.
Neurotransmitters
Neurotransmitters are chemicals in the brain that convey information throughout
the brain and body and signal nerve cells to tell the heart to beat, the lungs to breathe, and
the stomach to digest, as well as other body functions (Neurogistics, 2014).
Neurotransmitters also affect the body’s mood, sleep function, concentration, and weight.
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Neurotransmitters can cause unfavorable symptoms when out of balance (Neurogistics,
2014). In addition, stress can cause neurotransmitter levels to be out of their most
efficient range. The neurotransmitters responsible as stress indicators are: Epinephrine,
Norepinephrine, Dopamine, Serotonin, GABA, Glutamate, and PEA (Neurogistics,
2014).
Researchers place neurotransmitters into two categories: inhibitory and excitatory.
Inhibitory neurotransmitters-serotonin, GABA, and dopamine-help calm the brain by
preventing excitatory neurotransmitters from over stimulating the brain (Neurogistics,
2014). Excitatory neurotransmitters—dopamine, norepinephrine, epinephrine, and
glutamate—stimulate the brain and are responsible for many stimulatory processes in the
body (Neurogistics, 2014). When any of these neurotransmitters fall above or below
optimal levels, adverse health symptoms can occur (Neurogistics, 2014). Table 1 shows
clinical correlations of specific neurotransmitters to indications of stress and anxiety
when the neurotransmitters are not at optimal levels.
Chronic stress and anxiety increase the level of excitatory neurotransmitters in the
body. In response, the brain increases inhibitory neurotransmitters levels to bring balance
to neurotransmitters levels. When stress and anxiety persist, increased levels of inhibitory
neurotransmitter response may be inadequate to regain balance (Neurogistics, 2014). In
such cases, additional neurotransmitter support through diet or dietary supplements may
be indicated. If the balance is not restored, risks for complicating health issues and
immune challenges are increased (Neurogistics, 2014).
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Table 1
Neurotransmitter Clinical Correlations for Specific Disease State
Neurotransmitter

High Levels

Low Levels

Epinephrine

Anxiousness, focus and
concentration issues, sleep
difficulties

Focus and concentration
issues, fatigue, low libido,
weight issues

Norepinephrine

Anxiousness, focus and
concentration issues, low
mood, pain, sleep
difficulties, weight issues

Focus and concentration,
low mood, fatigue, low
libido, memory issues,
weight issues

Dopamine

Focus and concentration
issues, sleep difficulties

Urges, impulsivity,
cravings, anxiousness, focus
and concentration issues,
low mood, fatigue, low
libido, memory issues

Serotonin

Intestinal complaints, low
libido

Anxiousness, low mood,
intestinal complaints, low
libido, pain, sleep
difficulties, weight issues

GABA

Excessive energy,
anxiousness, sleep
difficulties

Anxiousness, sleep
difficulties,

Glutamate

Urges, cravings, focus and
concentration issues, low
mood, intestinal complaints,
pain, sleep difficulties,
weight issues

Fatigue, focus and
concentration

PEA

Sleep difficulties, mind
racing, anxiousness

Focus and concentration
issues, fatigue, memory
issues, weight issues,
difficulty thinking clearly

(adrenaline)

Neurogistics (2014).
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Prevalence of Caregiving in the United States
The National Alliance for Caregiving (2015) in collaboration with the American
Association of Retired Persons (AARP) conducted a study to present a portrait of
caregivers in the United States. The three-part study series examined caregiving trends.
The first phase of the study took place in 2004 and had a core focus on care-recipients.
The second and third phases of the study took place in 2009 and 2015. The later phases
focused more on caregivers and their caregiving role. For purposes of this study, the
researcher will only use findings from the 2009 and 2015 phases because the findings of
those phases align more with the research goals of this study.
Under the direction of Naiditch and Weber-Raley (2009), the core research areas
examined in the 2009 and 2015 were demographic characteristics of caregivers;
caregiving situation regarding responsibilities, intensity, and duration of care; and the
effect of the caregiver role on their personal life and health. Quantitative interviews were
conducted nationwide with 1,480 (N = 1,480) caregivers in 2009 and 1,248 (N = 1,248)
caregivers in 2015. Naiditch and Weber-Raley (2009) explained that comparisons should
not be drawn between the 2009 and 2015 findings. Although the 2015 study builds itself
from prior research phases, it was conducted during a technological shift requiring online
data collection. Prior research phases conducted data collection utilizing landline
telephones only. The researchers concluded that the 2009 and 2015 findings should be
viewed as isolated studies showing the prevalence of caregiving in the United States
without drawing comparisons. Table 2 shows the key findings in the 2009 and 2015
phases, respectively.
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Table 2
Key Demographic Findings
2009 Study
Gender
Male
Female
Age
18 to 34
35 to 49
50 to 64
65 to 74
75 or older
Race / Ethnicity
White
African-American
Hispanic
Asian-American
Other
Marital Status
Married
Living with partner
Single, never married
Separated, divorced
Widowed
Caregiver Household Income
Less than $49,999
$50,000 to $99,999
$100,000 or more
Employment Status
Employed providing care
Not employed providing care
Duration of care provided
Less than 6 months
6 months to 1 year
1 to 4 years
5 to 9 years
10 years or more

2015 Study

34%
66%

40%
60%

22%
29%
35%
9%
4%

23%
23%
34%
12%
7%

72%
13%
12%
2%
1%

62%
13%
17%
6%
2%

58%
5%
16%
14%
7%

57%
8%
19%
9%
7%

42%
61%
19%

47%
30%
23%

57%
43%

60%
40%

16%
18%
33%
13%
20%

31%
19%
27%
13%
10%

(National Alliance for Caregiving, 2015)
Caregiver Roles Across Different Care Recipient Diagnoses
Caregiving experiences vary with the type of illness, disorder, or disability of the
caregiving recipient. However, caregiving research over the past decade does not cover
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all possible caregiving experiences. The NAC (2015) identified three distinct illness
categories for people with progressive chronic illness: “gradual decline, steady
progression followed by a relatively clear short-lived terminal phase, and gradual decline
punctuated by brief episodes of accelerated decline followed by some recovery” (NAC,
2015, p. 4). These three categories are illness trajectories described for people with
chronic illness. Common chronic illnesses are Alzheimer, cerebrovascular accident,
cancer, congestive heart failure, and HIV/AIDS. Each of these illnesses impact the
characteristics of the care given by a caregiver.
Prolonged Gradual Decline
Alzheimer’s Disease and Related Disorders. Most research studies focus on
caregivers for Alzheimer’s disease or related disorders (ADRD). Of the four million
Americans living with ADRD, three million live at home (NAC, 2015). Alzheimer’s
cases are expected to reach 13.2 million by the year 2050. Caregiving for dementia is the
most difficult and time-consuming of all the types of caregiving. Twenty-four percent of
caregivers of dementia patients work upwards of 40 hours per week versus 16% of
nondementia caregivers (NAC, 2015).
Caregivers of dementia patients are under more stress, and spend less time
socializing with family and friends, than any other caregiver. This is largely due to the
“cognitive impairment, neuropsychiatric abnormalities, dysphoria, disinhibition,
delusions, and problematic behavior” that is typical with the disease (NAC, 2015, p. 8). It
was also found that caregivers of dementia patients have worse emotional and physical
health than caregivers for other illnesses (NAC, 2015).
Cerebrovascular Accident (CVA) or Stroke. In the United States, nearly
700,000 people suffer from strokes each year with 25% dying each year (American Heart
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Association, 2018). Survivors are usually dependent on long-term care. In fact, the NAC
(2015) reported stroke as the leading cause for long-term disability. The sudden
unexpected nature of strokes rarely leaves much time for preparing for caregiving roles.
Due to this sudden onset, caregivers often feel a lack of support from others. High
caregiving demands for this type of patient, mixed with caregivers feeling a lack of
support, can negatively impact their mental and physical health (Low, Payne, &
Roderick, 1999).
Steady Progression Followed by a Short-Lived Terminal Phase: Cancer
Cancer is the second leading cause of death in the United States (NAC, 2015).
Although cancer treatment has advanced, the five-year survival rate for all cancers is only
65% (Edwards et al., 2014). As with caregivers of patients with chronic disabilities,
cancer caregivers are at risk for psychological morbidity. Researchers found the rates of
depression of cancer caregivers increase from 20% when newly diagnosed to 50% when
the patient is terminally ill (Sherwood et al., 2008; Tomarken et al., 2008).
Cancer caregiving varies depending on the stage of illness. These stages include
diagnosis, treatment, remission, or palliative care. Caregivers typically try to obtain
information about the disease after diagnosis but are usually ignored by health care
providers (Rees & Bath, 2010). In the treatment phase, caregivers focus less on their own
needs and more on the needs of the patient for support. They also attempt to obtain
information on treatment procedures, side effects, and prognosis (Luker, Beaver,
Leinster, & Owens, 1996). During remission, caregiver stress decreases (Northouse,
Mood, Templin, Mellon, & George, 2010). However, a recurrence of the illness causes
continual caregivers’ psychological distress and social adjustments. During this time, the
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palliative phase demands more extensive personal care causing caregivers depression and
burdens to increase while their quality of life decreases (Grunfeld et al., 2011).
Pain is a major concern in cancer patients (McGuire, 2009). Although there have
been advances in treatment, 70% of patients with a terminal illness experience pain
(McGuire, 2009). Pain is viewed as a precursor to physical deterioration. Because of this
pain, caregivers report working with cancer patients as the most stressful human
experience (Powe & Finnie, 2003). This type of caregiver has higher levels of depression
and mood disturbances than those caregivers with pain-free patients (Hasson-Ohayon,
Goldzweig, Braun, & Gallinsky, 2010). In addition, caregivers deal with fears of patient
medication addiction and side effects (Hasson-Ohayon et al., 2010).
Gradual Decline With Brief Episodes of Accelerated Decline and Some Recovery
Congestive Heart Failure (CHF). Patients with severe CHF have the worse
quality of life of all chronic diseases; however, two-thirds of CHF hospitalizations are
preventable (Juenger et al., 2002). The researchers stated that patients do not follow
medical advice or do not seek help when symptoms occur. Strong relationships between
caregivers and patients decreases the number of readmissions (Juenger et al., 2002).
Empowering caregivers and allowing them to take part in discharge planning makes them
more accepting of the caregiving roles (Bull, Hansen, & Gross, 2000).
HIV/AIDS. The introduction of better medication has transformed acquired
immune deficiency syndrome (AIDS) from a rapid progressive illness to a chronic illness
(Welch & Morse, 2012). This improved survival rate results in a greater need for more
informal caregivers and palliative care. Patient and caregiver deal with comorbid diseases
like chronic obstructive pulmonary disease, diabetes, hypertension, and congestive heart
failure (Welch & Morse, 2012). Additionally, homophily explains the aspects of caring
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for a person living with HIV/AIDS (PLHA). This principle states that contact among
similar people occurs more often than between dissimilar people (McPherson, SmithLovin, & Cook, 2001). Seventy-five percent of HIV/AIDS patients are men. As a result,
over half of PLHA caregivers are men when compared to caregivers of other illnesses
(Centers for Disease Control and Prevention [CDC], 2016; NAC, 2015).
HIV is more common with ethnic minorities, IV drug users, and the poor (CDC,
2016; Karon, Fleming, Stekette, & DeCook, 2010). The CDC (2016) reported that 70%
of newly diagnosed cases are nonwhite. Because of the limited resources for receiving
formal care services available to nonwhites, ethnic minority caregivers provide the most
intensive AIDS care (Turner, Catania, & Gagnon, 2013). Twenty percent of cases are IV
drug users (CDC, 2016). It is typical for drug abusers to deplete their own resources and
be supportive of other’s emotional and financial resources. As a result, drug abusers are
more likely to rely on friends rather than family for caregiving (NAC, 2015). Burden for
this type of caregiver is increased because the caregiver often does not have legal rights
or benefits (NAC, 2015).
The CDC (2016) reported that AIDS is prevalent in youth and a leading cause of
death among 25 to 44-year olds. As a result, parents or those acting as surrogates for
minor children typically are the caregivers. However, since HIV/AIDS is unfortunately a
highly stigmatizing disease, caregivers may perceive stigma as guilt by association. They
may find themselves unwilling to disclose the patient’s diagnosis or the prevalence of
disease to avoid unwanted social reactions. In addition, they may feel socially distant
from family and friends when support is needed. They may even delay their own medical
needs for fear of stigmatization (Stetz & Brown, 2004).
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Other Illnesses
Additional caregiving roles of care recipients not included in the body of literature
would include those with a severe mental health diagnosis including Autism Spectrum
Disorder. As with AIDs, caregivers providing for this type of care recipient are typically
informal caregivers due to the stigma placed on those with mental health issues
(Saunders, 2013). Sometimes even the caregiver themselves feel marginalized and the
stigma placed on them. Often, they too feel inadequate or unprepared to handle the
episodic stressors that come with their caregiving role (Saunders, 2013).
Regardless of the illness cared for, caregiver outcomes have individual
differences. The stress process model explains these differences as that model has
identified risk and protective factors (Pioli, 2010). The components of the stress process
model are primary stressors, secondary stressors, and appraisal (Pioli, 2010).
Caregiver Stressors That May Lead to Increased Anxiety
Primary stressors include those stressors that directly impact the caregivers’
physical well-being. Stressors include the severity of patient illness and the required
physical task necessary to render the specific care. Caregivers typically help patients with
activities of daily living (ADL) (BLS, 2016). These include bathing, dressing, grooming,
eating, toileting, and transferring patients from bed or chair. In some cases, they
additionally provide instrumental activities of daily living (IADL) like food shopping,
meal preparation, housework, and transportation (BLS, 2016). The BLS (2016) also
stated that 15% of all caregivers administer medications and change dressings.
Patient suffering also impacts caregiver well-being (Papastavrou et al., 2011).
Researchers found that caregiver perception of patient suffering contributes to caregiver
depression more than patient’s severity of illness, behavior, or time in care. Furthermore,
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changes in patient suffering were associated with caregiver’s depression and burdens
(Papastavrou et al., 2011). Compassion derives from a sense of shared suffering coupled
with the caregiver’s desire to help alleviate it. Compassion can cause distress if the
caregiver feels an inability to relieve the patient’s suffering (Papastavrou et al., 2011).
Primary stressors typically overlap into a second set of stressors that include
feelings of being underappreciated, social, and financial pressures, and transitions. The
BLS (2016) reported that 62% of caregivers are married or have a live-in partner, 59%
have additional jobs, and 37% are parents who are raising children. These demands often
conflict with providing care for patients because of conflicting roles and challenging
demands. In addition, researchers found that caregivers report they have no time to
socialize and incur substantial financial responsibility. Preoccupation with financial
obligations may cause caregivers to be less attentive to patient care (Jardim & Pakenham,
2009).
Caregiving transitions are also stressors for caregivers (Jardim & Pakenham,
2009). For example, as the dynamics of care changes so does caregiving responsibilities.
With changing responsibilities, caregivers relinquish or modify their roles that can often
lead to greater challenges for other family members and friends (Jardim & Pakenham,
2009). Caregivers of dementia patients are at risk for depression following their patient’s
nursing home placement, as the caregiving role does not end (MacNeil et al., 2010).
Caregivers continue to visit the patient and may provide physical care during those visits.
Poor communication and negative interactions with nursing home staff can have an
impact on caregivers’ well-being (MacNeil et al., 2010). Additionally, end-stage
caregiving often thrusts caregivers into their greatest burden. The NAC (2015) reported
that caregivers at this stage spend from 100 to 125 hours a week providing care for
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hospice patients. Furthermore, they typically handle decisions dealing with life-sustaining
technology.
In addition to primary and secondary stressors, appraisals impact caregiving
outcomes. Appraisals are how caregivers handle or react to stressors. It plays a greater
role in their well-being than primary or secondary stressors (Haley et al., 2011). As they
perform their caregiving, caregivers are constantly appraising the impact and demand on
themselves and judging whether their resources are adequate to cope with that impact.
Emotional and behavioral responses are created that can contribute to health outcomes
(Haley et al., 2011). Additionally, the ethnicity of the caregiver can affect those health
outcomes.
Ethnic differences exist in appraisals. Researchers found that African American
caregivers report more positive caregiving and less stress than other ethnicities (Chyung
et al., 2018). Because they were not found in noncaregivers, they also found that
appraisal differences due to ethnicities are specific to caregivers. Factors such as
motivation for providing care, coping strategies to deal with caregiving experiences, and
greater availability for support all play a part in these differences (Chyung et al., 2018).
Researchers also found ethnic differences in attitudes toward caregiving that affected
appraisals (Pinquart & Sorensen, 2005). Western cultures value individualism, whereas
non-western cultures value collectivism such as familism (Pinquart & Sorensen, 2005).
Compared to White caregivers, African American and Hispanic caregivers generally
report a stronger caregiving ethic and cultural reasons for caregiving (Pinquart &
Sorensen, 2005).
Although a greater network of support implies greater availability of resources,
researchers found that kinship networks among Hispanic caregivers can cause greater
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distress (Pinquart & Sorensen, 2005). Latino caregivers report less support is available to
them than White caregivers because they are less willing to ask for advice or discuss their
feelings with their support network (Pinquart & Sorensen, 2005). These kinship networks
could be a barrier to seeking formal caregiving if the family keeps problems, they
consider to be potentially embarrassing to the family, to themselves.
Although differences in caregiving outcomes depend on the interaction between
caregiver and recipient, studies show caring for individuals with an illness contributes to
psychiatric and physical morbidity. Pinquart and Sorensen (2005) found that caregivers
experience more stress, depression, and lower well-being than non-caregivers.
Additionally, differences were significant for spousal caregivers and women. Researchers
found spousal caregivers to have worse outcomes because they provide higher intensity
hands-on care. Additionally, women are at higher risk because they are more conscious
of their emotions, tend to be more sympathetic, and are willing to report negative feelings
(Baider & Bengel, 2010).
Providing care for others may influence physical health (Pinquart & Sorensen,
2005). Caregivers may ignore self-care needs and not engage in preventative health
behaviors (Schulz & Sherwood, 2008). Additionally, researchers found that caregiver
chronic stress may compromise immunity to disease, cardiovascular reactivity, wound
healing (Schulz & Sherwood, 2008). Schulz and Sherwood (2008) found there to be a
63% higher mortality risk in caregivers than non-caregivers.
Depression Among Caregivers
Multiple studies recognized that caregiver burden was detrimental to caregiver
mental health and caused depression rates between 20% and 80%, compared to 13% for
the general population, (Cameron et al., 2016; Geng et al., 2018). Depression rates were a
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function of severity of physical and psychological impairment of patient, duration of care,
and degree of lifestyle changes (Cameron et al., 2016; Pinquart & Sorensen, 2005).
Depressive symptoms extend beyond well beyond the period of caregiving (Cameron et
al., 2016). Research indicated that 41% of former caregivers of a spouse dementia
experienced mild to severe depression three years after termination of caregiving
responsibility (Denno et al., 2013). A longitudinal study of 280 caregivers found that one
year after completed caregiving for stroke victims the caregiver depression rate remained
three times greater than the general population (Cameron et al., 2016). Actual caregiver
depression rates are moderated by several factors (Pinquart & Sorensen, 2005).
Subjective well-being, physical health quality and quantity of non-caregiver social roles,
social roles, socioeconomic status, quality of social relations, health promoting habits,
personality, and genetic factors moderate caregiver burden and depression.
Some caregivers with symptoms of depression do not recognize the symptoms in
themselves, while others have difficulty admitting they feel depressed (Geng et al., 2018).
Lingering stigma regarding mental illness can make depressive thoughts and feelings
difficult to express for fear of judgment from others (Geng et al., 2018). Depression is a
normal pervasive response to caregiver burden. Caring burden is a broad term covering
ministering to the ill and may be compounded by: (a) illness-related behavioral problems,
disorientation, and shifts in personality; (b) increased need for supervision and loss of
spare time; (c) isolation from friends and family: (d) patients inability to appreciate the
sacrifice involved in caregiving; and I progressive deterioration of the care receiver,
which reduces the potential for positive outcomes from caregiving sacrifices (Denno et
al., 2013).
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Researchers research indicated that depression rates for cancer caregivers increase
from 20% for newly diagnosed and expand to 50% for terminally ill patients (Sherwood
et al., 2008). Cancer patient caregivers significantly influence the patient’s disease
management and palliation, which may adversely affect their mental and physical health
in the longer run (Geng et al., 2018). Increasing caregiver stress during prolonged
caregiving produced measurable changes in neurohormonal and inflammatory processes
that quadruple the risk of depression and may increase morbidity and mortality among
caregivers (Geng et al., 2018).
Prolonged patient suffering erodes caregiver resiliency and empathy manifests in
feelings of despair (Papastavrou et al., 2011). Researchers found that caregiver perception
of patient suffering contributes to caregiver depression more than patient’s severity of
illness, behavior, or time in care (Sherwood et al., 2008). Normal deterioration in patient
health and increases in suffering were associated with caregiver’s depression.
Compassion derives from a sense of shared suffering coupled with the caregiver’s desire
to help alleviate it, which may cause feelings of helplessness from the inability to relieve
patient suffering (Papastavrou et al., 2011).
Caregiving transitions produce incremental stressors from logistical, financial,
and emotional sources (Jardim & Pakenham, 2009). As the caregiving setting evolves, so
do caregiving challenges. Caregivers may relinquish or modify their roles in a manner
which causes the need to manage other caregivers in the family or professionally. For
example, movement of a patient into a nursing home evokes feelings of bereavement for
the loss of a family member’s capability, and because it is the beginning of a new set of
responsibilities and challenges (MacNeil et al., 2010). Caregivers nursing home visits
with the patient and may involve physical care, interaction with staff, searches for
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alternative therapies or the need for final arrangements. Poor communication and
negative interactions with nursing home staff and family members adversely affect
caregivers (MacNeil et al., 2010). End-stage caregiving often thrusts caregivers into their
greatest burden with caregivers spending from 100 to 125 hours a week providing
hospice care.
Differences in caregiving outcomes often depend on factors well beyond
caregiver’s capacity and evokes a sense of failure, which contributes to depression and a
variety of psychiatric and physical maladies (Geng et al., 2018). Research indicated that
caregivers experience significantly more stress, depression, and lower well-being than
family-related non-caregivers. Women were significantly more likely to experience
depression than their male peers. Women are at higher risk because they are more
conscious of their emotions, tend to be more sympathetic, and are willing to report
negative feelings (Baider & Bengel, 2010). Also, at high risk for poor health outcomes
were spousal caregivers because they provide higher intensity hands-on care.
Past Caregiving Interventions by Category
Considering the impact of caregiving, researchers have conducted few studies on
interventions for caregivers. A review of literature within the past decade reveals four
studies on caregivers of those diagnosed with dementia or Alzheimer’s. Furthermore, the
research shows past caregiving interventions fall into two categories: (a) reducing amount
of caregiving and (b) providing information and improving coping skills. All four studies
fall within the category of providing information and improving coping skills.
Reducing Amount of Caregiving
Respite care is temporary substitute relief for caregivers. There are two basic
types of respite care. Centered-based programs are a type of respite care that provide day
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or night care for a certain number of hours. In contrast, institutional respite care provides
care when caregivers need multiple days of relief for holidays, sickness, or when
caregiving responsibilities interfere with personal demands (Gottlieb & Johnson, 2010).
The National Alliance for Caregiving (2015) reported that to date no clear evidence
supports the conclusion that respite care reduces the burden on caregivers or improves
their mental health. One probable cause of this conclusion is that caregivers typically use
respite care as a last resort when responsibilities become overwhelming (Gottlieb &
Johnson, 2010). Additionally, caregivers may see respite as unacceptable because they do
not want to leave the patient (Gottlieb & Johnson, 2010).
Providing Information and Improving Coping Skills
Support groups build understanding between participants surrounding topics, so
they feel comfortable discussing their problems, successes, or feelings about caregiving.
They are vehicles to disseminate information, psychosocial support, or education.
However, Brodaty et al. (2003) found that increased caregiving knowledge is not related
to social or psychological outcomes. Psychoeducational programs information and
resources to caregivers regarding the disease process and train them on how to provide
adequate services.
Additionally, some psychoeducational interventions include some form of
psychotherapy. The major disadvantage of this type of intervention is its intensive
professionally-led nature. Self-reliance and independence are important values to
caregivers (McMillan et al., 2006). Therefore, many of these intervention programs have
low participation rates and high attrition rates (McMillan et al., 2006).
Lopez et al. (2007) examined a stress management program for informal
caregivers. Participant requirements were (a) age 18 and older, caring for a dependent
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individual over the age of 60 who scored a 1 on the Katz Index of Activities of Daily
Living which measures level of disability, (b) lived at same residence as patient, (c) was
solely responsible for providing care, and (d) had provided care for patient for at least six
months. Additionally, participants must not have received any other treatment and have
shown some evidence of emotional distress as measured by Beck Depression Inventory
(BDI) or the Hospital Anxiety and Depression Scale. One hundred twenty-three
caregivers were assessed. Of that number, 14 (11%) did not meet requirements and 18
(15%) declined to participate. Ninety-one (N = 91) caregivers were used for the sample.
A multigroup experimental design was used with repeated measures (Lopez et al.,
2007). Participants were randomly grouped into one of three groups: (a) a group that
received the program through a traditional format, (b) a group that received the program
with minimal therapist contact, and (c) a control group that was placed on a waiting list
(Lopez et al., 2007). Likewise, professionals were randomly selected to facilitate each
treatment. Treatment lasted two months for all groups.
The traditional group received eight 60-minute weekly sessions. Participants were
in direct contact with a therapist. They received written exercises and homework between
sessions. In contrast, the minimal therapist contact group received three 90-minute
sessions at four-week intervals. Between sessions, caregivers were directed to review
strategies learned and to go over new ones. The waiting list group did not receive any
type of treatment or help. Participants were administered both pre- and posttreatment
with the Katz Index of Activities of Daily Living, Hospital Anxiety and Depression
Assessment, BDI, Zarit Burden Interview, and the Maladaption Scale (Lopez et al.,
2007). Data analysis showed caregivers in the traditional group experienced the greatest
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reduction in anxiety and depression compared with caregivers in the minimal therapist
contact group (Lopez et al., 2007).
Limitations to the Lopez et al. (2007) study included the absence of a blind
interview for performing assessments. There might have been possible bias since the
interviewer knew the participant’s experimental assignment. Another limitation was that
there was only one measure posttreatment. Therefore, it is unclear if treatment effects
were short-term or continued.
Williams et al. (2010) analyzed a video-based coping skills (VCS) training program for
Alzheimer’s disease and related dementia (ADRD) patients. Their objective was to
decide if VCS with telephone coaching would reduce psychosocial and biological distress
in caregivers (Williams et al., 2010). One hundred sixteen (N = 116) ADRD caregivers
were recruited over a two-year interval through advertisements, support groups, and
referrals from an Alzheimer’s disease research center in North Carolina (Williams et al.,
2010). Participants were screened for medical problems and those who were noncaregivers. Then they were randomly placed into two groups: a VCS training group or a
waiting list control group.
On day one, participants in the VCS group were given study materials and
informed of the telephone coaching they would be receiving (Williams et al., 2010).
Psychological and biological distress markers were immediately tested, and then again at
seven weeks, three months, and six months. Test measurements used were the CES-D,
Minnesota Multiphasic Personality Inventory-based Cook–Medley Hostility Scale,
Perceived Stress Scale, Pittsburgh Sleep Quality Index, Revised Scale for Caregiving
Self-Efficacy, Spielberger STAI, and the Spielberger State-Trait Anger Inventory
(Williams et al., 2010). Participants received $30 for each module completed and $60 for
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the fourth visit (Williams et al., 2010). The VCS program consisted of ten 7-minute video
modules that taught 10 coping skills that dealt directly with caregivers (Williams et al.,
2010). Coping skills taught were (a) changing reactions, (b) evaluating reactions, (c)
empathizing, (d) listening, I increasing awareness and objectivity, (f) increasing positive
interactions, (g) problem solving, (h) using assertion, (i) speaking clearly, and (j) saying
no (Williams et al., 2010). Participants watched a dramatization of a caregiving situation
that was linked to a specific coping skill. They were required to complete two modules a
week and all exercises and homework assignments for each module.
VCS participants also received telephone coaching during the five-week duration
of the program. Trained telephone coaches called participants weekly to teach that week
is two coping skills (Williams et al., 2010). Telephone coaches followed a structured
format including the 10 coping skills and coaching goals. Videos presented caregiving
scenarios with stress-producing circumstances. They were used to normalize caregiving
experiences and to enable caregivers to admit or verbalize difficult thoughts or behaviors
(Williams et al., 2010). The wait list control group were tested at the seven-week, threemonth, and six-month intervals, but received no treatment.
Williams et al. (2010) researchers found that VCS training with the inclusion of
telephone coaching was statistically significant in reducing psychosocial and biological
measures of distress in ADRD caregivers. The main limitation with this study dealt with
the treatment effects. It was unclear if there was a true effect or response bias because
participants were paid to complete the study. Also, this study did not show whether
treatment effects were short-term or continued after treatment.
O’Connell et al. (2010) evaluated a wellness guide for new older caregivers living
in a community setting. The Health and Wellbeing Project was initiated in 2003 at a
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major university in the United States and was conducted in three stages. In the first stage,
researchers identified specific needs of caregivers by performing health needs
assessments. Surveys were mailed to 226 caregivers in a region with an invitation to one
of two focus groups. In the second stage, researchers collected the data from the focus
group and developed a wellness guide based on recurring themes using qualitative
analysis. In the third stage, new caregivers evaluated the wellness guide for its usefulness
and effectiveness as well as its impact on their health and well-being. O’Connell et al.
(2010) found that caregiver wellness guides based on caregiver needs assessment is an
acceptable source for new caregivers. However, a major limitation of the wellness guide
was whether it continued to have lasting effects on addressing the needs of new
caregivers.
Epstein-Lubow et al. (2011) investigated a mindfulness-based stress reduction
training program for caregivers. Nine (N = 9) female caregivers ages 48 to 73 participated
in 80 thirty-minute weekly classes geared toward mindfulness-based stress reduction.
Mindfulness mediation is a type of meditation that allows one to focus their attention on
bodily sensations and thoughts in the present with a goal to reduce anxiety. Depressive
symptoms, burdens, perceived stress, anxiety, general health, and mindful attention were
all measured at pre-intervention, post-intervention, and one-month follow-up.
Results revealed a decrease in depressive symptoms, perceived stress, and burden
during the eight-week intervention. Stress and burden continued to reduce after the onemonth follow-up, while depressive symptoms returned to baseline. Mindful attention
increased for the duration of the study. Additionally, participants reported continued use
of mindfulness techniques during the one-month follow-up. Limitations to this study
included the challenge of identifying subpopulations of caregivers that would utilize
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mindfulness techniques. All these interventions relied upon various forms of behavior
and psychological modifications with some sort of therapist involvement. One
intervention does not rely so much on behavior modification as it does on a physiological
method: cranial electrotherapy stimulation.
Cranial Electrotherapy Stimulation (CES)
An alternative anxiety reduction method that has gained attention in literature is
Cranial Electrotherapy Stimulation. CES uses small electrical impulses that pass across
the head from electrodes placed on, or near, the ears. Pulse rates can vary from .5 to 100
HZ in different CES devices, and stimulation intensities can range from 0 – 1.5 mA via
sinusoidal or modified square waves (Regence Blue Cross Blue Shield, 2018). A review
of the literature on CES is more challenging due to the variety of names given for the
same method. Other names include transcranial electrical stimulation, cerebral
electrostimulation, electrosleep, and alphasleep (Gibson & O’Hair, 1987; Kirsch, 2002;
Kirsch & Smith, 2004).
Electromedicine can be traced back in history for thousands of years. The first
reference of electromedicine occurred in 46 A.D. by the Greek physician Scirbonius
Largus. He described an application of a black torpedo fish to ease chronic pain
(Kirsch, 2002). In 1903, Leduc and Rouseau were the first to experiment with low
currents across the scalp. This was called electrosleep. It would later be introduced to the
United States in the 1960s (Appel, 1972; Brown, 1975; Gilula & Kirsch, 2005). Since
then, researchers experiment with multiple versions of electromedicine. It has now
officially become known as cranial electrotherapy stimulation (Anan’ev et al., 1960;
Douglas, Larson, & Sances, 1970; Knutson, Tichy, & Reitman, 1956; Robinovitch,
1914).
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Food and Drug Administration (FDA) and CES
The FDA currently approves Cranial electrotherapy stimulation for anxiety,
insomnia, and depression (Allevia Health, 2014). In 2012, the FDA stated CES is a class
II neurological device that applies electrical current to a patient’s head to treat insomnia,
depression, or anxiety. This type of device was defined as the most stringent regulatory
category for devices. Class II devices are those for which insufficient information exists
to assure safety and effectiveness solely through general or special controls” (FDA, para
9). These devices require pre-market FDA approval which is defined as “the required
process of scientific review to ensure the safety and effectiveness of Class” (FDA, para
11). Currently eight companies have FDA approval to sell CES devices (Gilula & Kirsch,
2005). One such company is Electromedical Products International, Inc (EPI). EPI
markets their device using the name Alpha-Stim They received FDA approval in May
1992 (Allevia Health, 2014). The 510(k)-pre-market notification number is K903014
(Alpha Stim, 2008). To meet FDA approval, the device must meet certain standards
which include:
A microprocessor controller box and skin electrodes. The small Controller box is
software controlled low-intensity output. Current ranges from 0-600
Microamperes typically set at 0.5 Hz. Additional frequencies at 1.5 and 100Hz are
available for the physician’s use. The waveform is a bipolar asymmetric rectangle
shape with a 50% duty cycle, 0 net current. Current is applied using silver
electrodes with self-adhesive pads applied to the ear lobes (Allevia Health, 2014).
Simply stated, the CES unit is a small device that utilizes software to produce low
frequency waves conducted through ear clip electrodes.
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How CES Works
It is not clear how CES works. However, several researchers have attempted to
answer the question (Giordano, 2014). Since the initial studies, researchers proposed
several theories. One such theory is that micro current waveforms projected by the CES
unit stimulate and change neurological nerve cells that in turn fine-tune the brain. It was
hypothesized that the raphe-nuclei is stimulated when ear clip electrodes are clipped to
the earlobes near the mastoid bone (Giordano, 2014). Giordano (2014) stated:
This neurological fine-tuning is called modulation, and occurs either as a result of,
or together with the production of a certain type of electrical activity pattern in the
brain known as an alpha state which can be measured on brain wave recordings
(called electroencephalograms, abbreviated EEG). Such alpha rhythms are
accompanied by feelings of calmness, relaxation and increased mental focus. The
neurological mechanisms that are occurring during the alpha state appear to
decrease stress effects, reduce agitation, and stabilize mood, and regulate both
sensations and perceptions of particular types of pain. (p. 1)
Gilula and Kirsch (2005) discussed the CES effect on the limbic system, reticular
activating system (RAS), the hypothalamus, and the thalamus on the nervous system.
Toriyama (1975) suggested CES works through the parasympathetic nervous system.
Smith (2002) stated that “neurotransmitters that are out of homeostasis due to some prior,
reasonably prolonged stress reaction, whether it be psychological or physical such as
drug abuse, will come back into homeostasis and any concomitant anxiety, depression or
sleep problems will subside” (p. 5). Childs and Price (2007) stated that anti-aggressive
effects of CES generate due to an increase of alpha waves created. It was also reported
that CES may augment prescribed antipsychotics and mood stabilizers.
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CES Studies
Currently, there are more than 175 published studies for CES reporting significant
results with most of them reporting a positive reduction in anxiety and/or stress.
Approximately 75 were designed to measure anxiety reduction using CES. Some of those
studies are Briones & Rosenthal, 1973; Feighner, Brown, & Oliver, 1973; Frankel,
Buchbinder, & Snyder, 1973; Gibson & O’Hair, 1987; Gilula & Kirsch, 2005; Hearst,
Cloninger, Crews, & Cadoret, 1974; Heffernan, 1996; Jemelka, 1975; Kirsch & Nichols,
2013; Krupitsky et al., 1991; Passini, Watson, & Herder, 1976; Phillip, DemotesMainard, Bourgeois, & Vincent, 1991; Rosenthal, 1972; Strentzsch, 2009; Taylor, Lee, &
Katims, 1991;Von Richthifen & Mellor, 1980; Voris, 1995; Winick, 1999).
Thirty-five studies reported using a double-blind technique. In these studies,
participants were divided into two groups: One group received CES and the other
received a sham treatment. Eleven of these studies investigated anxiety (Briones &
Rosenthal, 1973; Feighner et al., 1973; Hearst et al., 1974; Heffernan, 1996; Jemelka,
1975; Passini et al., 1976; Phillip et al., 1991; Rosenthal, 1972; Von Richthifen & Mellor,
1980; Voris, 1995; Winick, 1999). Additionally, three studies used a placebo control
designed to rule out placebo effects during the administration of CES as opposed to sham
CES. Neither found placebo effects (Lichtbroun, Raicer, & Smith, 2001; Strentzsch,
2009; Taylor et al., 1991).
Anxiety research that uses CES dates from 1968 to the present. Most of these
studies were conducted in the 1970s (Kirsch, 2002). Negative outcome studies were all
between 1965 and 1980 (Kirsch, 2002). No Alpha-Stim has ever received a negative
outcome (Kirsch, 2002). Most of the negative outcome studies addressed insomnia. Only
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four measured anxiety (Moore, Mellor, Standage, & Strong, 1975; Passini et al., 1976;
Tomsovic & Edwards, 1973; Von Richthifen & Mellor, 1980).
Gilula and Kirsch (2005) examined the effectiveness of CES as opposed to
medication in treating depression. The goal of the study was to determine if evidence
supported CES as an alternative to pharmaceuticals. Researchers found an equal benefit
over placebo for CES opposed to medication. In contrast to pharmaceuticals and its
various side effects, CES has no reported serious side effects (Gilula & Kirsch, 2005).
Numerous methods have been used to measure effectiveness of CES, including
electrocardiogram (EKG), electroencephalogram (EEG), electromyogram (EMG), skin
conductance, blood pressure, pulse, respiration, heart rate, body chemistry, peripheral
tension, BDI (Beck et al., 1988), Hamilton Anxiety Scale, Hamilton Depression Scale,
Global Evaluations, Minnesota Multiphasic Personality Inventory (MMPI), State/Trait
Anxiety Inventory, Taylor Manifest Anxiety Scale, and the Zung Depression Scale
(Kirsch, 2002). Few studies have used neurotransmitter levels as an outcome measure
(Frankel et al., 1973; Krupitsky et al., 1991; Scherder et al., 2003; Shealy, Cady, CulverVeehoff, Cox, & Liss, 1998; Shealy, Cady, Wilkie, Cox, & Clossen, 1989).
Summary
This chapter presented cranial electrotherapy stimulation as an alternative method
of reducing anxiety and depression in caregivers. The review of literature indicates that
multiple research studies of caregiving interventions have been conducted. However,
many of these studies failed to show whether treatment effects were short-term or had
long lasting effects beyond treatment. The history of cranial electrotherapy stimulation
was briefly outlined, and numerous detailed studies supported the FDA-approved device
as an effective way to reduce anxiety, depression, and insomnia.
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Chapter 3
Methodology
Currently, no other research study has investigated interventions for depression
and anxiety symptom reduction for caregivers outside the interventions of reducing the
amount of caregiving or providing information and coping skills. The purpose of this
experimental pretest post-test two-group double-blind design study was to examine the
efficacy of cranial electrotherapy stimulation (CES) to reduce anxiety and depressive
symptoms for a sample of 35 caregivers.
Research Design
This study uses an experimental pretest post-test two-group double-blind design.
Researchers may unintentionally change research outcomes in a variety of ways. They
may offer a smile (which offers a sense of encouragement) for a right answer or offer a
frown for a wrong answer (Krathwohl, 1998). This design ensures that both the
administrator and those receiving treatment are blind to which group receives the
different treatments (Krathwohl, 1998). The sham CES treatment group consists of the
participants who are given treatment that was meant to not have an effect, and the active
CES treatment group consisted of participants who were given treatment that is meant to
have an effect. This study uses an experimental pretest post-test 2-group double-blind
design. This design ensures that both the administrator and those receiving treatment are
blind to which group receives what (Krathwohl, 1998). Electromedical Products
International, Inc. (EPI) provided the CES devices to the researcher. Before delivery to
the researcher, EPI coded the devices as active or sham. Neither the researcher nor the
subjects knew whether a device was active or sham until the completion of the study.
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Assumptions and rationale for design. This study is designed to respond to
limitations represented in the current body of literature regarding interventions for
anxiety and depressive symptoms in caregivers. CES is an electronic device approved by
the U.S. Food and Drug Administration (2018) for reducing symptoms if anxiety,
depression, and insomnia. Current literature has identified a primary limitation of a lack
of double-blinding experimentation necessary to eliminate researcher bias. To ensure
double-blindness, EPI will code all CES devices as either active or sham before sending
the devices to the researcher. After completion of the three-week treatment protocol and
final data gathering, EPI will inform the researcher which CES devices are active and
which are sham.
The researcher selected this population due to multiple studies in the body of
literature that found caregivers have high risk of adverse health, psychological, and
financial effects because of increased anxiety and depressive symptoms related to their
caregiver role (Ashley et al., 2011; Harris et al., 2011; King et al., 2010; MacNeil et al.,
2010; Martin et al., 2011; Pioli, 2010; Turner et al., 2010). Traditional treatment methods
for reducing anxiety and depressive symptoms for caregivers include either reducing
caregiving or providing information and coping skills (NAC, 2015). Because there has
been high dropout rates in studies using these traditional treatment methods (McMillan et
al., 2006), the researcher believes that this population would benefit most from an
alternative treatment method that requires little, if any, modification of the caregiving
routine or additional time taken away from caregiving and other usual activities.
Participants. To be eligible, participants must be living in the Houston area, be at
least 18 years old, and be currently providing care to an individual who is disabled,
chronically ill, or cognitively impaired.
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Sampling. This study used a sample size of 40 caregivers in the Houston area. The
researcher recruited participants from caregiving agencies and organizations in the
Houston area by sending out emailed invitations to invite participants to the study.
Risks. There were both physical and psychological risks to participants. Physical
reactions to the skin, dizziness, and nausea may occur when using the CES device.
Psychological risk may include re-emergence of negative feelings when taking the
Beck’s Depression Index (BDI) and State-Trait Anxiety Inventory (STAI).
Confidentiality and Informed Consent. All data collected was confidential
including test results, demographic questionnaires, and tracking sheets. The informed
consent is the only place the participants’ names will appear. Names will not appear on
the STAI, the BDI, or demographic questionnaire. All final data were used only for
publication and research purposes.
Costs. There were no costs associated with this study for participants. However,
participants will need to devote time to complete the 3-week CES protocol and track their
use of the CES device each day on the tracking sheet (Appendix A).
Role of the Researcher. The researcher’s role is to find participants, ensure
integrity of the study, answer questions of the participants, collect data, and interpret
findings.
Data Collection Procedures
Prior to data collection. Permission for the study was obtained from the St.
Mary’s University Institutional Review Board (Appendix B). An invitation (Appendix
C)) and common asked question brochure were then sent out to area caregiver agencies to
invite caregivers to be a part of the study in order to reach a sample size of 40
participants. Participants were asked if they have received treatment from a mental health
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care provider prior to participating in the study. If yes, their data was not used in the
study. All participants were given a participation letter, informed consent form
(Appendix D), common questions brochure, demographic questionnaire (Appendix E),
State-Trait Anxiety Inventory (Appendix F), and Beck’s Depression Inventory to
complete. If participants receive a score of 20 or above on the State-Trait Anxiety
Inventory or Beck’s Depression Inventory they were given a referral list of mental health
care providers. The consent form and information sheet were kept separate from the data
containing each participant’s name, contact information, and assigned number identifying
each participant. The assigned number will also be placed on participants pre and post
surveys. The surveys were kept separate from the consents and information sheets so that
the surveys remain unidentifiable.
Participants were asked to use their CES device each day for 60 minutes for three
weeks. The researcher will teach participants how to use the CES device when devices
are delivered to each participant. See training protocol (Appendix G). Upon completion
of the 3-week CES protocol, participants will repeat the test measurements taken at the
start of the study. Participants were asked if they received any treatment from a mental
health care provider since starting their participation in the study. If yes, their data will
not be used in the study. Participants with significant missing data were removed from
data analysis. Data collection will continue until participant numbers are met with
completed data. After a participant has completed the study and returned the device, the
researcher will cut out the participant’s name and contact information from the master list
and will shred this information.
The STAI is a 40-item scale used to assess two types of anxiety: trait anxiety and
state anxiety (Spielberger, 1983). Trait anxiety is how prone one is to perceive stressful
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situations as threatening. State anxiety is how intensely one will respond to a perceived
threatening situation (Spielberger, 1983). Under psychological stress, test-retest
reliability ratings for the STAI assessment tool vary between .89 and .94. However, there
is a larger variance of .16 and .94 in the populations. Comparing both forms to all
populations creates a .65 correlation between all responses (Spielberger, 1983).
The BDI is a 21-item, self-report inventory that measures attitudes and the
symptoms of depression (Beck et al., 1988). Developed in several forms, including
computerized administration, it can be completed in approximately 10 minutes. A fifthgrade reading level is required to understand the questions (Beck et al., 1988). Internal
validity ranges from .73 to .92 with a mean of .86. It demonstrates high internal validity,
with alpha coefficients of .86 and .81 for psychiatric and non-psychiatric populations
(Beck et al., 1988).
Data Analysis Procedures
The data collected from the pre- and posttest results of the STAI scores, BDI
scores, and demographic data sheet were entered in a dataset using SPSS. Descriptive
statistics and frequency tables were executed using information gathered from the
demographic questionnaire. After completing descriptive analysis, inter-item reliability
analysis were conducted on the STAI and BDI measures to determine reliability in the
sample. After reliability analysis, a repeated measure multivariate analysis of variance
(MANOVA) were conducted to address variance between pre- and posttest scores for the
STAI and Beck’s Depression Inventory scores. Results will then be examined for the
relationship between outcome measures related to anxiety and depressive symptoms. On.
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Security and Confidentiality of Data
This study will require paper records of the informed consent form, demographic
questionnaire, State-Trait Anxiety Inventory, Beck Depression Inventory, and the
tracking sheet. The informed consent were kept separate from all other data in order to
ensure confidentiality. They were sent to the Sponsored Programs Academic Research
and Compliance office at St. Mary’s University where they were stored and disposed of
according to federal regulations. All other hard copy data were stored in a locked cabinet
in a locked room in the researcher’s house and will have codes associated with the
participants data forms. All electronic data forms were password protected. All data were
kept for five years and then shredded by the researcher. No follow up treatment was
offered to any participants.
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Chapter 4
Data Analysis
The purpose of this experimental pretest post-test two-group double-blind design
study was to examine the efficacy of cranial electrotherapy stimulation (CES) to reduce
anxiety and depressive symptoms for a sample of 35 caregivers. The research design
required that neither the administrator or those receiving treatment knew which CES
device was active and which were sham. To ensure double-blindness, Electromedical
Products International, Inc. (EPI) coded all CES devices as either active or sham prior to
sending devices to the researcher. After completion of the three-week treatment protocol
and final data gathering, the researcher opened the sealed envelope from EPI that
informed the researcher which CES devices were active and sham based on serial
numbers. The researcher was then able to identify the participants who were in the
treatment group and those who were in the control group.
Participants had been trained on how to use the CES device and instructed to use
the CES device each day for 60 minutes for three consecutive weeks. Prior to the first
CES session, each participant completed both the Beck Depression Index (BDI) and
State-Trait Anxiety Inventory (STAI) to create a bassline. Upon completion of the thereweek CES protocol, participants again completed the BDI and STAI. This chapter
includes a discussion of the data analysis results. Descriptive statistics were employed to
characterize the study sample demographically and summarize study variable data for the
treatment and control groups.
Data Collection
The study sample included 35 caregivers willing to follow the CES protocol for a
three-week period and complete the BDI and STAI pre and post CES protocol. Eighteen
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caregivers were randomly assigned CES devices. All participants completed the CES
protocol, BDI, and STAI. Two participants chose not to provide certain demographic data
and were included in the study. Otherwise, no other data issues emerged.
Findings
Tables 3 through 11 summarize demographic data distributions for control and
treatment groups based on age, caregiver status, caregiver hours, caregiver experience,
ethnicity, gender, income, marital status, and, number of individuals cared for, and
patient’s illnesses. As shown in Table 3, for gender distribution, of the 35 participating
caregivers, the sample included 24(68%) females, 10(29%) males, and 1(3%) who
provided no gender data. Control and distribution groups included similar distributions by
gender with approximately two-thirds female.
Table 3
Gender Distribution by Group
Group
Control

Treatment

Gender
Female
Male
Unknown
Total

n
12
4
1
17

%
70.6
23.5
5.9
100.0

Female
Male
Unknown
Total

12
6
0
18

66.7
33.3
0.0
100.0

As shown in Table 4, both groups contained a wide range of ages, from 18 to 30
age group through the 60+ age group. The age distributions between the control group
and treatment group were similar. Approximately two-thirds were between age 31 and
50.
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Table 4
Age Distribution by Group
Group
Control

Age
18 to 30
31 to 40
41 to 50
51 to 60
60+
Total

n
2
4
7
2
2
17

%
11.8
23.5
41.2
11.8
11.8
100.0

Treatment

18 to 30
31 to 40
41 to 50
51 to 60
60+
Total

2
3
9
0
4
18

11.1
16.7
50.0
0.0
22.2
100.0

Table 5 details caregiver status by group. Caregiver status distributions between
the control group and treatment group were similar. Between 82.4% and 94.4% were
informal caregivers.
Table 5
Caregiver Status Distribution by Group
Group
Control

Treatment

Caregiver Status
Formal
Informal
Total

n
3
14
17

%
17.6
82.4
100.0

Formal
Informal
Total

1
17
18

5.6
94.4
100.0

As shown in Table 6, the ethnicity distribution contained various ethnicities. The
ethnicity distributions between control and treatment groups were similar. Black and
Latino represented 64.7% and 89%, respectively.
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Table 6
Ethnicity Distribution by Group
Group
Control

Treatment

Ethnicity
Asian
Black
Latino
P. Islander
White
Unknown
Total

n
1
9
2
1
2
1
17

%
5.9
52.9
11.8
5.9
11.8
5.9
100.0

Asian
Black
Latino
P. Islander
White
Unknown
Total

0
12
4
0
1
1
18

0
66.7
22.2
0
5.6
5.6
100.0

As shown in Table 7, the marital status distribution between the control and
treatment groups were similar. In the control group, 35.5% of the participants were
married or cohabitating. In the treatment group, 44.4% of the participants were married or
cohabitating.
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Table 7
Marital Status Distribution by Group
Group
Control

Treatment

Marital status
Single
Cohabitating
Married
Divorced
Widowed
Unknown
Total

n
8
3
3
1
1
1
17

%
47.1
17.6
17.6
5.9
5.9
5.9
100.0

Single
Cohabitating
Married
Divorced
Widowed
Unknown
Total

7
2
6
2
0
1
18

38.9
11.1
33.3
11.1
0.0
5.6
100.0

As shown in Table 8, in the control group 12 (70.0%) participants reported
providing more than 11 hours of caregiving per week, while in the treatment group only 8
(50%) participants reported providing more than 11 hours of caregiving per week. The
number of caregiver hours was somewhat greater for the control group. The overall
sample commits substantial proportions of their week to caregiving.
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Table 8
Caregiver Hours Distribution by Group
Group
Control

Treatment

Caregiver hours
1 to 10 hours
11 to 20 hours
31 to 40 hours
Greater than 40 hours
Unknown

n
5
5
4
3
0

%
29.4
29.4
23.5
17.6
0.0

Total

17

100.0

1 to 10 hours
11 to 20 hours
31 to 40 hours
Greater than 40 hours
Unknown
Total

9
4
3
1
1
18

50.0
22.2
16.7
5.6
5.6
100.0

As shown in Table 9, the treatment group was more varied in the amount of
caregiving years. The treatment group had more relatively new caregivers and a greater
number of longer experienced caregivers than the control group. Most of the control
group had between 2 and 5 years of experience.
Table 9
Years as Caregiver Distribution by Group
Group
Control

Years as caregiver
Less than 2 years
2 to 5 years
Greater than 5 years
Unknown
Total

n
5
11
0
1
17

%
29.4
64.7
0.0
5.9
100.0

Treatment

Less than 2 years
2 to 5 years
Greater than 5 years
Unknown
Total

10
3
4
1
18

55.6
16.7
22.2
5.6
100.0
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As shown in Table 10, both the treatment group and control had similar numbers
of patients for whom they provided care. The control group had three participants who
provided care to three or more patients. The treatment group had more participants who
provided care to two patients, but this group had no participants who provided care to
three or more patients.
Table 10
Number Cared for Distribution by Group
Group
Control

Treatment

Number cared for
1
2
3
Greater than 3
Total

n
13
1
2
1
17

%
76.5
5.9
11.8
5.9
100.0

1
2
3
Greater than 3
Total

14
4
0
0
18

77.8
22.2
0.0
0.0
100.0

As shown in Table 11, the control group income primary distribution was as
follows: 13 (76.6%) reported income between $31,000 and $69,000, while the treatment
group had 9 (50%) report income between $31,000 and $79,000. The treatment group
income skewed somewhat higher than the control group.
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Table 11
Income Distribution by Group
Group
Control

Income
Less than 30K
31k to 39k
40k to 49k
50k to 59k
60k to 69k
70k to 79k
80k to 89k
90k to 99k
Total

n
1
4
2
4
3
1
1
1
17

%
5.9
23.5
11.8
23.5
17.6
5.9
5.9
5.9
100.0

Treatment

Less than 30K
31k to 39k
40k to 49k
50k to 59k
60k to 69k
70k to 79k
80k to 89k
90k to 99k
Total

3
0
2
7
1
2
3
0
18

16.7
0.0
11.1
38.9
5.6
11.1
16.7
0.0
100.0

Statistical Assumptions
Paired sample t-test were conducted to assess hypotheses 1 and 2, and Pearson
correlation was employed to test hypothesis 3. The assumption is that pre and post BDI
and STAI data for both the control and treatment groups were approximately normally
distributed, and a scatterplot reveals a linear relationship. Parametric statistical methods
such as Pearson correlation and paired sample t-tests, assume that dependent variable
data (BDI score and STAI score) are approximately normally distributed and linear.
As shown in Table 12, Shapiro-Wilk’s was conducted on the eight subsets of
dependent data depicted to test for normality and linearity (Leedy, Ormrod, & Johnson,
2019).Correlation statistics demonstrated that Pre-BDI, Pre-STAI, Post-BDI data for both
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treatment and control groups met the assumptions for linearity. None of the eight
Shapiro-Wilk’s tests for normality were significant at p < .05, meaning that all eight
subsets of dependent variables depicted in Table 12 met the assumption for normality.
Table 12
Test of Normality
Shapiro-Wilk’s
Control
Pre-BDI
Pre-STAI
Post-BDI
Post-STAI
Treatment Pre-BDI
Pre-STAI
Post-BDI
Post-STAI

Statistic
.923
.961
.803
.814
.932
.938
.946
.946

df
17
17
17
17
18
18
18
18

Significance
.164
.648
.119
.112
.208
.263
.360
.372

Hypothesis Tests
RQ1: Did caregivers receiving active CES treatments experience a greater
reduction of anxiety symptoms than the caregiver control group?
Ho1: Participants who received active CES treatments did not experience
significantly greater anxiety reduction, as measured by STAI scores, as compared
to the control group.
Ha1: Participants who received active CES treatments experienced significantly
greater anxiety reduction, as measured by STAI scores, as compared to the control
group.
Table 13 reports pre and post STAI score mean, standard deviation, and standard
error for the control and treatment groups. A paired-samples t-test was conducted to
compare control group STAI score before and after CES treatment. For the control group,
the 10.53 mean difference in STAI scores between pre (M = 42.18, SD = 13.28) and post
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(M = 31.65, SD = 5.65) treatment was statistically significant; t(16) = 3.119, p = .001. A
paired-samples t-test was conducted to compare treatment group STAI score before and
after CES treatment. For the treatment group, the 12.05 mean difference in STAI scores
between pre (M = 43.61, SD = 10.99) and post (M = 31.56, SD = 4.11) treatment was
statistically significant; t(17) = 4.189, p = .001. However, there was no significant
difference in pre and post STAI score improvement (Mean difference = 1.52) between the
treatment group and the control group t(34) = .345, p = .732. Therefore, the null
hypothesis was accepted, there was no difference in anxiety symptom reduction between
the control group and the treatment group.
Table 13
STAI Scores by Group
Group
Control

Dependent Variable Mean

Treatment

Pre-STAI
Post-STAI
Pre-STAI
Post-STAI

42.18
31.65
43.61
31.56

Mean Diff.

n

SD

Std. Error

-10.53
-12.05

17
17
18
18

13.28
5.65
10.99
4.11

3.22
1.37
2.59
0.97

RQ2: Did participants receiving active CES treatments experienced a greater
reduction of depressive symptoms, as measured by BDI scores, compared to the control
group?
Ho2: Participants who received active CES treatments did not experience greater
depressive symptom reduction, as measured by BDI scores, as compared to the
control group.
Ha2: Participants who received active CES treatments experienced significantly
greater depressive symptom reduction, as measured by BDI scores, as compared
to the control group.
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Table 14 reports pre and post BDI score mean, standard deviation, and standard
error for the control and treatment groups. A paired-samples t-test was conducted to
compare control group BDI score before and after CES treatment. For the control group,
the 9.12 mean difference in BDI scores between pre (M = 18.41, SD = 13.12) and post (M
= 9.29, SD = 7.29) treatment was statistically significant; t(16) = 4.139, p = .001. A
paired-samples t-test was conducted to compare treatment group BDI score before and
after CES treatment. For the treatment group, the 10.39 mean difference in BDI scores
between pre (M = 16.11, SD = 11.31) and post (M = 5.72, SD = 3.89) treatment was
statistically significant; t(17) = 4.189, p = .001. However, there was no significant
difference in pre and post BDI score improvement (Mean difference = 1.57) between the
treatment group and the control group t(34) = .415, p = .675. Therefore, the null
hypothesis was accepted, there was no difference in depressive symptom reduction
between the control group and treatment group.
Table 14
BDI Statistics by Sample
Mean
Control
Treatment

Pre-BDI
Post-BDI
Pre-BDI
Post-BDI

18.41
9.29
16.11
5.72

Mean
Diff.
-9.12
-10.39

n

SD

Std. Error

17
17
18
18

13.12
7.29
11.31
3.89

3.18
1.76
2.66
0.91

RQ3: What is the relationship between anxiety symptoms, as measured by the
STAI, and depressive symptoms, as measured by the BDI, in caregivers?
Ho3: There is no significant relationship between STAI scores and BDI
scores for caregivers.
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Ha3: There is a significant relationship between STAI scores and BDI
scores for caregivers.
Pearson correlation statistics were conducted to address Research Question 3.
Table 15 depicts correlations and significance for the pre BDI – STAI relationship and
the post BDI – STAI relationship. The pre-CES treatment BDI- STAI relationship was
strong and statistically significant (r = 0.575, p < .000). The pre-CES treatment BDISTAI relationship was strong and statistically significant (r = 0.668, p < .000). Therefore,
the null hypothesis is rejected, there was a strong significant correlation between BDI
score and STAI score for the overall sample.
Table 15
BDI - STAI Correlations

Post-STAI
Pre-BDI

Pearson Correlation
Sig. (2-tailed)
Pearson Correlation
Sig. (2-tailed)

Post-BDI
.575**
.000
---
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Pre-STAI
--.668**
.000

Chapter 5
Discussions, Conclusions, and Recommendations
The purpose of this experimental pretest post-test two-group double-blind design
study was to examine the efficacy of cranial electrotherapy stimulation (CES) to reduce
anxiety and depressive symptoms for a sample of 35 caregivers. To study this
phenomenon, the researcher drew data from among 35 caregivers to determine whether
CES treatment helped them experience a decrease in anxiety and depressive. The
researcher hypothesized that participants who received treatment would experience
reductions in anxiety symptoms (as gauged by STAI scores) and depressive symptoms
(as gauged by BDI scores).
The methodology chosen used an experimental pretest post-test two-group
double-blind design to ensure that both the administrator of the test and those receiving
the treatment were blind to which group received the genuine treatment and which
received the sham treatment. Data was collected from CES devices used by participants
and analyzed for both pre- and post-test results on STAI and BDI scores. The findings of
the study, reported in Chapter IV, are discussed in the following sections.
Participant Demographics
A non-random convenience sampling technique was employed to recruit and
select participants. More than 80% of all 35 participants were informal caregivers, and
there was no publicly available demographic information regarding the general
population of informal caregivers in Houston. Thus, the researcher was unable to
compare the participants to the general population of informal caregivers in Houston.
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Interpretation of the Findings
Three research questions were developed to guide the current study. The first
research question for the study was as follows:
RQ1: Did caregivers receiving active CES treatments experience a greater
reduction of anxiety symptoms than the caregiver control group?
Findings indicated that there was no statistically significant difference in anxiety
symptom reduction between CES treatment and control groups, even though both groups
reported experiencing significantly lower anxiety symptoms. As such, CES treatment did
not appear significantly more effective in reducing anxiety symptoms than a placebo. The
findings were not consistent with proposals regarding CES, which researchers indicated
may be useful for addressing a variety of conditions through the stimulation of raphenuclei (Giordano, 2014). Researchers previously broadly indicated that the use of CES
could influence multiple parts of the brain and nervous system, such as the hypothalamus,
thalamus, and totality of the nervous system (Gilula & Kirsch, 2005).
Smith (2002) also indicated that neurotransmitters may fall out of homeostasis
because of prolonged stress reactions in response to both physical and psychological
stimuli. The use of CES was noted as an effective means of reducing anxiety in numerous
studies (Briones & Rosenthal, 1973; Feighner et al., 1973; Frankel et al., 1973; Gibson &
O'Hair, 1987; Gilula & Kirsch, 2005; Hearst et al., 1974; Heffernan, 1996; Jemelka,
1975; Kirsch & Nichols, 2013; Krupitsky et al., 1991; Passini et al., 1976; Phillip et al.,
1991; Rosenthal, 1972; Strentzsch, 2009; Taylor et al., 1991; Von Richthifen & Mellor,
1980; Voris, 1995; Winick, 1999). As such, it was anticipated from the existing literature
that CES would help to address anxiety symptoms in caregivers.
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Despite all the evidence suggesting that CES should be useful in treating anxiety,
the current study did not seem to yield similar results. Consequently, that places the
current study as the outlier regarding the rest of the literature. The findings suggest there
may be specific conditions among caregivers that influence their anxiety that the use of
CES does not address.
RQ2: Did participants receiving active CES treatments experience a greater
reduction of depressive symptoms, as measured by BDI scores, compared to the control
group?
Findings indicated that there was no statistically significant difference in
depressive symptom reduction between CES treatment and control groups, even though
both groups reported experiencing significantly lower depressive symptoms. As such,
CES treatment did not appear significantly more effective in reducing depressive
symptoms than a placebo. This finding was inconsistent with the expectations generated
from the literature. Past research suggested that CES should help address negative mental
health conditions. However, this was not found in the current study. Once again, this
suggests that caregivers may have unique situations that lead to depressive symptoms,
meaning that alternatives to addressing those symptoms may be necessary rather than
employing CES. Given the above findings, the research produced within the current study
contradicted previous indications in the literature that CES may help.
RQ3: What is the relationship between anxiety symptoms, as measured by the
STAI, and depressive symptoms, as measured by the BDI, in caregivers?
After testing to determine the relationship between anxiety symptoms and
depressive symptoms in caregivers, the researcher found that there was a strong
association between both types of symptoms among caregivers as gauged using STAI and
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BDI scores. Previous indications from the National Alliance for Caregiving (2015)
indicated that caregiving work may lead to both anxiety and depression, therefore, the
findings that both occurred among caregivers was consistent with the previous literature.
However, there was little else identified in the literature suggesting that the two may
occur in tandem. As such, the current findings were relatively novel when contextualized
within the larger literature and added a unique contribution to the existing research.
Limitations of Study
The choice of various research methodologies can have limitations (Krathwohl,
2009). It is up to researchers to recognize and determine if the benefits of the chosen
study design outweigh the cost of the chosen approach (Krathwohl, 2009). Within the
context of the current study, the choice of research design was deemed of greater benefit
than the associated costs. Regardless, the identified limitations may have reduced the
efficacy of the study, though steps were taken to address these limitations to the greatest
degree possible.
One limitation recognized was the lack of a true randomization process for
sampling the identified population. For this study, participants were recruited from the
Houston area. However, owing to variation in caregiving work schedules, there was a
lack of available caregivers willing to participate at any given time. As such, sampling
could not be randomized. A second limitation to the study was the nature of the topic.
The topic of CES may have seemed uncomfortable to some caregivers, who may not
have felt inclined to participate (biasing the sample), or who answered without full
honesty during the study.
The small size sample due to the practical limitations limited generalizability of
study findings, and the non-random sampling technique suggests the sample may not be
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representative of caregivers in the Houston area. The following practical limitations limit
findings. First, participant sessions were not monitored, so it was possible that some
participants did not use the devices as required for the study. Second, it is possible that
caregiving could have changed during the use of the device or that the caregivers
experience stressors during the study affecting their posttest scores. Third, participants
could have guessed that they had been given active or sham devices, which affected their
posttest scores. Fourth, although the samples were somewhat similar, the control sample
reported spending more hours giving care and more years of experience giving care than
the treatment group. It is possible that these differences affected the outcome. Fifth, the
treatment protocol was for 21 days with immediate posttest at the end without follow-up.
it was not known if additional change could have occurred with longer term CES usage.
Recommendations
The fact that both groups improved in both symptoms suggests that caregivers can
reduce their anxiety and depressive symptoms with minimal intervention. Caregivers may
just need to believe they are doing something or feel hope that improvement can occur.
This would imply that any intervention could result in improvement. A few practical
recommendations can be made from the current study. In short, it did not seem that CES
helped to address either anxiety or depression in caregivers significantly more than the
placebo. Given that as the case, no recommendation could be made suggesting that CES
be applied among caregivers as a means of addressing these symptoms. Considering the
lack of effectiveness of CES, such devices should not be employed among caregivers for
addressing issues of anxiety and depression. As such, the most practical recommendation
that could be made based on the current research would be for organizations employing
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caregivers to seek out alternative methods for addressing both anxiety and depression
among these individuals.
Regarding research recommendations, it is clear from the findings that the current
research conflicted with the vast amount of literature regarding CES use for anxiety and
depressive symptom reduction. The body of literature indicated that CES should have had
some statistically significant greater impact on these symptoms than a placebo. Yet, the
current research did not reach this objective. Considering that the findings of the current
research were in such contrast to the previous findings, further investigation of this
population is necessary. First, there is the issue of the small sample drawn for this
research. The sample size may have disproportionately impacted the current study
findings. As such, expanding the sample to increase the power may yield different results
from those reached in the current version of the study. One recommendation for future
research is to include a more representative sample of the population in the higherpowered sample.
A second recommendation for future research would be to examine the nature of
the sample. Research could explore whether there are specific characteristics that
distinguish the jobs of caregivers from roles that others fill in other careers. If so, this
may help to explain why the use of CES did not provide greater help in addressing the
anxiety and depressive symptoms experienced among this sample. A qualitative
investigation of these caregivers could yield data on unique phenomenon common to
their roles that may make caregivers more resistant to positive outcomes from CES
treatment.
A third recommendation for future research would be to analyze the nature of the
currently completed research itself. The current research, given its outlier status, may
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necessitate replication to determine whether the same results can be achieved. If not, then
it may indicate a fundamental flaw in the design of the research that would need to be
addressed before the research can be repeated. Considering the outlier status of the
findings, it brings to question whether there may have been a design flaw that could have
affected the outcomes. As such, replication attempts may help clarify whether the current
study’s findings typify the target population.
Another recommendation would be to replicate the study with low cost treatments
that would not be time consuming for caregivers. Considering that both CES and a
placebo yielded a significant reduction in anxiety and depressive symptoms, it is possible
that low cost treatments that do not require great time commitments from caregivers
would be effective. For example, training caregivers in breathing exercises and
mindfulness, which could be employed during caregiving activities, could assist
caregivers in reducing their anxiety and depressive symptoms. One of the reasons for the
decision to study CES with this population is because caregivers often do not have the
time to devote to attend counseling groups or to participate in self-care activities that take
them away from their caregiving responsibilities. If a low-cost treatment that does not
take the caregivers’ time were identified, this could help many caregivers.
Implications
Given that CES failed to impact anxiety and depression in the sample drawn for
this study, the implication is that CES may not be as successful at addressing these issues
as the vast amount of prior literature suggests. If this is the case, then it may necessitate
revisiting old literature, and reviewing the studies, to assess the quality of each study’s
design to determine whether the findings were valid. A second implication of the study
stemmed from the association of anxiety and depression, both occurring among the
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sample. If anxiety and depression occur together, then it implies they may have similar
roots and develop along similar mental pathways. In this regard, the implication is that
caregivers may have both anxiety and depressive symptoms manifest as a response to the
duties the individuals must complete and the emotional experiences that caregivers have
as they care for their patients.
Conclusion
The purpose of this experimental pretest post-test two-group double-blind design
study was to examine the efficacy of cranial electrotherapy stimulation (CES) to reduce
anxiety and depressive symptoms for a sample of 35 caregivers. To complete this study,
35 participants were recruited into a pretest post-test two-group double-blind study. The
underlying hypothesis was that participants who received treatment would experience
reductions in anxiety and depressive symptoms.
Following an analysis of the data, the researcher’s hypotheses that CES would
help reduce symptoms of anxiety and depression were not supported. This contextualized
the current study as an outlier against the larger body of literature, which suggested that
CES should have a greater positive impact on symptoms than a placebo. The lack of
greater improvement through CES suggested that the current study may have included
unique features within the research design that produced significantly different findings
from those previously found in the literature.
Based on the current research, CES cannot be recommended as a treatment for
anxiety and depressive symptoms among caregivers. The study indicated that anxiety and
depressive symptoms both occurred among this population and that both the treatment
and control groups experienced lowered anxiety and depressive symptoms. As such, there
continues to be an ongoing need to address the mental health needs of caregivers and find
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varying ways to treat anxiety and depressive symptoms in this population. Because both
the treatment and the placebo were effective in lowering anxiety and depressive
symptoms, counselors and other mental health professionals should keep an open mind to
creatively treating caregivers. It is possible that caregivers could lower their anxiety and
depressive symptoms just by participating in treatments that they believe will result in
change. Thus, future research should investigate low cost treatments that do not require a
lengthy time commitment from caregivers to address these symptoms rather than relying
on CES to help address anxiety and depressive symptoms among caregivers.
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Appendix B
Institutional Review Board Approval
June 3, 2019
Reginald Jefferson
Dept. of Counseling
St. Mary's University
DELIVERED BY EMAIL TRANSMISSION
Dear Mr. Jefferson:
The IRB has approved the study Jefferson (M. Harper, faculty sponsor), An
Examination of Cranial Electrotherapy Stimulation (CES) on Anxiety and Depressive
Symptoms of Caregivers: A Double-Blind Experimental Study. If research
participants have any questions about their rights as a research subject or concerns
about this research study please contact the Chair, Institutional Review Board, St.
Mary’s University at 210-436-3736 or email at IRBCommitteeChair@stmarytx.edu.
Dan Ratliff, Ph.D.
IRB Chair
St. Mary’s University
The proposal is determined to meet criteria for expedited review [45 CFR 46.110].
The research protocol has been approved by the St. Mary’s IRB for the period of May
15, 2019 to May 14, 2020.
You may collect data from human subjects according to the approved research
protocol. The approval stamp must appear on any Information Form or Informed
Consent Form approved by the IRB (jpeg file attached).
If, at any time, you make changes to the research protocols that affect human
participants, you must file a “Changes to Approved IRB Protocol and/or
Unanticipated Problems” form. Changes must be reviewed and approved by IRB
before proceeding with data collection.
Dan Ratliff, Ph.D.
IRB Chair
CC: Melanie Harper, PhD, Faculty Sponsor
Attachment: IRB Approval Stamp jpeg file
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Appendix C
Invitation to Participate in Research Study
Dear Potential Participant,
My name is Reginald Jefferson, and I am currently recruiting participants to be
part of a study to increase understanding of the effectiveness an intervention designed to
reduce stress in caregivers. To be eligible for the study, participants must be at least 18
years old, live in the greater Houston area, and currently participate in a caregiving role
for at least one person who is disabled, chronically ill, or cognitively impaired. As a
caregiver you were a huge asset to this study.
You were asked to complete a consent form and demographic information sheet
before the study and stress-related symptoms questionnaires before and after the study.
The study entails you using a device that is FDA approved to reduce stress, depression,
insomnia, and anxiety. You were required to use it for 60 minutes a day for 3 weeks. The
device is palm size, functional, and mobile, allowing for easy use. Using this device will
not get in the way of caregiving responsibilities.
There is no cost to you for participating in the study. However, you may
experience benefits of relief from stress and anxiety symptoms. For participating in the
study, you were entered in a drawing for a $50 VISA gift card.
If you are willing to participate, please suggest a day and time when we can meet,
and I will make myself available to you. If you have any questions, please don’t hesitate
to ask. I can be reached at (713) 452-0614.
Thank you,
Reginald Jefferson, Ph.D. Candidate, St. Mary’s University
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Appendix D
Informed Consent for Participation
St. Mary’s University
CONSENT FOR PARTICIPATION IN A RESEARCH PROJECT
Title:

An Examination of Cranial Electrotherapy Stimulation (CES)
on Depression and Anxiety Symptoms of Caregivers.

Principal
Investigator:

Reginald Jefferson, MS, MA, NCC, LPC-S, LMFT
Department of Counseling and Human Services
St. Mary’s University
(713) 452-0614

I am being asked to participate in the above-named project. My participation in
this study is entirely voluntary and I may refuse to participate or may decide to cease
participation once the study has begun. Should I withdraw from this study, which I may
do at any time, or should I refuse to participate in the study, my decision will involve no
penalty or loss of benefits to which I am otherwise entitled. I am being asked to read the
consent form carefully and were given a copy of it to keep. I was told the purpose of the
study was to attempt to determine the effectiveness of an alternative method for reducing
stress-related depressive and anxiety symptoms in caregivers.
I was also informed of the following research procedures: First, I were asked to
fill out a demographic information sheet about age, gender, ethnicity, marital status,
work status, type of caregiver, length of time in a caregiver role, illnesses of care
recipient(s), and annual income. Next, I were asked to fill out the State-Trait Anxiety
Inventory and Beck’s Depression Inventory to assess for anxiety and depressive
symptoms that I experience. I will then be randomly assigned to one of two groups: active
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Appendix D (cont.)
treatment and sham treatment. Neither I nor the researcher will know which
group receives the active
treatment. I am asked to follow the treatment protocol of use, which is one hour
per day each day for three consecutive weeks.

Every effort was made to maintain the confidentiality of my study records. I have been
specifically told that the information gathered in this study were coded to protect my
privacy and confidentiality. All data were coded with the number assigned to me at the
beginning of the study. The list pairing participant names and participant numbers were
kept separate from the data and will only be available to the principal investigator,
Reginald Jefferson, MS, MA, LPC-S, LMFT.

I have been advised that the data collected from the study were used for educational and
publication purposes; however, I will not be identified by name. The confidentiality of the
data was maintained within allowable legal limits. I have been told that the investigator
has the right to withdraw me from this study at any time.

The investigator has offered to answer all my questions. If I have additional questions
during the course of this study about the research or any related issue, I may contact the
principal investigator, Reginald Jefferson MS, MA, LPC-S, LMFT at (713) 452-0614 or
via email reginaldjefferson@Stmarys.edu or you may contact Melanie Harper, Ph.D., St.
Mary’s University, (210) 438-6400.
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My signature below acknowledges my voluntary participation in this research project.
Such participation does not release the investigator, institution, or sponsor from their
professional and ethical responsibilities to me. I have read the information provided
above and had my questions answered to my satisfaction. I voluntarily agree to
participate in this study. After it is signed, I will receive a copy of this consent form.

______________________________________
Name (Print)

_______________________________________
Signature of Participant

__________________
Date

_______________________________________
Signature of Principal Investigator

__________________
Date

If you have any questions about your rights as a research subject or concerns about
this research study please contact the Chair, Institutional Review Board, St. Mary’s
University at 210-436-3736 or email at IRBCommitteeChair@stmarytx.edu. ALL
RESEARCH PROJECTS THAT ARE CARRIED OUT BY INVESTIGATORS AT
ST. MARY'S UNIVERSITY ARE GOVERNED BY THE REQUIREMENTS OF
THE UNIVERSITY AND THE FEDERAL GOVERNMENT.
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Appendix E
Demographic Questionnaire
ID # ________________
Please do not write your name on this form. It were stored separately from any other
information that you complete during this study and will not be linked with your
responses in any way. The information will allow us to provide an accurate description of
the sample.
For the following items, please select the one response that is most descriptive of you or
fill in the blank as appropriate.
Age: __________
Gender:
o Male
o Female
o Other
Ethnicity:
o Asian or Pacific Islander
o Black/African American (Non-Hispanic)
o Native American
o Latino/Hispanic
o Asian Indian
o Caucasian/White
o Puerto Rican
o Other________________________________
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What is your marital status?
o Single
o Cohabitating with partner/significant other
o Married
o Divorced
o Widowed
o Other
Work Status:
o Part-Time
o Full-Time
What type of caregiver are you?
o Informal caregiver
o Formal caregiver
How long have you been in your caregiving role?
o Less than 2 years
o Two to 5 years
o Greater than 5 years
To what chronic illnesses do you provide care?
o Alzheimer’s Disease
o Dementia
o Vascular Dementia
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o Cerebrovascular Accident (CVA) / Stroke
o Cancer
o Congestive Heart Failure
o Mental Illness/Mental Retardation
o HIV/AIDS
o Other
What is your annual income (Or combined income if you are married/cohabitating)?
o Less than $30,000
o $31,000 to $39,000
o $40,000 to $ $49,000
o $50,000 to $59,000
o

$60,000 to $69,000

o $70,000 to $79,000
o $80,000 to $89,000
o $90,000 to $99,000
o $100,000 and above

99

.
Appendix F
State-Trait Anxiety Inventory Sample and Permission Letter
For use by Reginald Jefferson only. Received from Mind Garden, Inc. on March 28, 2015
Self-Evaluation Questionnaire
STAIAD Short Form Y-1
Please provide the following information:
Name

Date

Age

Gender (Circle) M F Other

Directions: A number of statements which people have used to describe themselves are
given below. Read each statement and then circle the appropriate number to the right of
the statement to indicate how you feel right now, that is, at this moment. There are no
right or wrong answers. Do not spend too much time on any one statement but give the
answer which seems to describe your present feelings best. Use the following scale:
1) NOT AT ALL 2) SOMEWHAT 3) MODERATELY SO 4) VERY MUCH SO
1. I feel calm.............................................................................................. 1 2 3 4
2. I am tense............................................................................................... 1 2 3 4
3. I feel at ease........................................................................................... 1 2 3 4.
4. I am presently worrying over possible misfortunes ............................. 1 2 3 4
5. I feel frightened..................................................................................... 1 2 3 4
Copyright © 1968, 1977 by Charles D. Spielberger. All rights reserved in all media.
Published by Mind Garden, Inc. www.mindgarden.com
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For use by Reginald Jefferson only. Received from Mind Garden, Inc. on March 28, 2015
To Whom It May Concern,
The above-named person has made a license purchase from Mind Garden, Inc. and has
permission to administer the following copyrighted instrument up to that quantity
purchased:
State-Trait Anxiety Inventory for Adults
The four sample items only from this instrument as specified below may be included in
your thesis or dissertation. Any other use must receive prior written permission from
Mind Garden. The entire instrument may not be included or reproduced at any time in
any other published material. Please understand that disclosing more than we have
authorized will compromise the integrity and value of the test. Citation of the instrument
must include the applicable copyright statement listed below.
Sample Items:
I feel at ease
I feel upset
I lack self-confidence
I am a steady person
Copyright © 1968, 1977 by Charles D. Spielberger. All rights reserved in all media.
Published by Mind Garden, Inc. www.mindgarden.com
Sincerely,
Robert Most
Mind Garden, Inc.
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Appendix G
CES Training Protocol
Cranial Electrotherapy Stimulation Training Protocol
1. You are asked to complete the 3-week protocol by using your device each day
consecutively for the entire 3-week period.
2. The CES device has been preset to run for 60 minutes each time you use it.
3. The manufacturer has preset each device to be active or sham as this is part of the
blinding process. Until the study ends, the researcher does not know which
devices are set to be active or sham.
4. To use your device, place one drop of saline solution on each ear clip.
5. Place an ear clip on each ear lobe
6. Turn device on.
7. Press Start and let run for 60 minutes.
8. After the device shuts off, remove the clips from your ear lobes.
9. Record daily participation on the tracking sheet.
10. Repeat steps 4-9 daily for 3 weeks.

102

Vita
REGINALD JEFFERSON, M.A., NCC, LPC-S, LMFT
Education
St. Mary’s University - San Antonio, Texas
June 2005 – Present
Doctor of Philosophy in Counseling Education and Supervision student
Specializations in Neurofeedback and Play Therapy
Master of Arts in Community Counseling, Graduated December 2008
Prairie View A&M University - Prairie View, Texas
Master of Science in Human Sciences, Graduated May 2002
Bachelor of Science in Biology, Graduated December 1997
Work Experience
IAH Secure Adult Detention Facility / MTC Medical, Inc. – Livingston, Texas
October 2016 – Present
Mental Health Professional: Oversee all behavioral health programming at IAH Secure
Adult Detention Facility. Provide diagnostic behavioral health assessments, treatments
plans, and counseling services to ICE detainees in custody and housed at the facility.
Provide reports and statistical information to detention facility administrative staff.
United Behavioral Health – Houston, Texas
March 2014 – Present
Care Advocate: A&T Provider Line collaborates with providers and facilities to define
precipitants, symptoms, recovery and resiliency needs, desired outcomes and
interventions. Determine appropriate levels of care placement based on clinical
presentation and risk factors. Conducts focused facility-based reviews effectively and
efficiently. Gather consistent clinical information to assess clinical needs. Obtain biopsychosocial data and co-morbid conditions. Identify needed resources. Demonstrate
clinically sound judgment by appropriately authorizing the level of care based on clinical
presentation, risk factors, Coverage Determination or Level of Care Guidelines. Initiate
discharge planning.
The Bair Foundation – Houston, Texas
June 2012 – February 2013
Therapist: Provide therapeutic services to children, adolescents, adults, and families with
mental health issues in the home of the client. Facilitated therapeutic services in
accordance to the Bair Foundation’s mission and values. Completed diagnostic
behavioral health assessments, develops behavioral health treatment plans, performs
clinical back-up and administrative duties in the absence of the Director or Supervisor.

103

.
Banyan Tree Family Counseling Center – Houston, Texas
January 2011 – Present
Owner/Therapist: Oversee the daily activities of the counseling center including, but not
limited to operations, marketing, strategy, financing, and compliance with safety
regulations, sales, and public relations. Provide counseling and mental health wellness
services to individuals, families, children, and couples to help them resolve crisis and
concerns as well as find balance in mental health status.
Cypress Creek Hospital – Houston, Texas
February 2009 – April 2012
Therapist: Provide counseling services to individuals, families, and groups regarding
mental illness. Develop treatment plans, completes psychosocial history, and perform
other case management duties for assigned patients. Attends team and therapy meetings
when appropriate and provide consultation to treatment team including psychiatrists and
other clinical staff. Interfaces with Utilization Review on a regular basis to determine
patient treatment needs within managed care counseling.
Family Time Foundation, Inc. - Humble, Texas
January 2006 – July 2011
Therapist: Provide outreach and counseling services individuals, couples, children, and
families in crisis. Instruct parenting workshops to couples going through divorce
involving children and those who have lost their children to Child Protective Services.
Fort Bend County Juvenile Detention Center - Richmond, Texas
August 2004 - January 2005
Counselor: Provide counseling services to detainees and their families. Conducted and
facilitated group counseling sessions with emphasis on cognitive modification and
relaxation techniques. Interviewed and evaluated all individuals for specific services
needed. Report findings to detention center staff and court personnel.
Mental Health Mental Retardation Authority of Harris County - Houston, Texas
October 2002 - March 2004
Service Coordinator: Provided mental health services that include, but not limited to:
treatment plan implementation, counseling and therapy, group facilitating, referral,
linkage, service coordination, rehabilitative services, and community outreach to juvenile
and adult ex-offenders (ages 16-adult) with a diagnosis of mild to severe and persistent
mental illness. Provide training and support to both clients and their family members in
the areas of homelessness, interpersonal skill limitations, medical issues, and all other
stress related issues.
Teaching Experience
University of Phoenix Online - Houston, Texas
January 2006 – December 2009
Faculty: Provide online guidance and counseling to students while teaching courses in the
areas of Child Development, Adult and Family Development, and Professional, Ethical,
and Legal Issues in Human Services.
104

.

Publications
St. Mary’s University – San Antonio, Texas
January 2010 – Present
Dissertation in Process: EXAMINATION OF CRANIAL ELECTROTHERAPY
STIMULATION (CES) ON DEPRESSIVE AND ANXIETY SYMPTOMS OF
CAREGIVERS: A Double-Blind Experimental Study

105

